CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC: Form 990, tax year 2015

View the entire original 990 at ProPublica ↗

Organization: CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC (EIN 91-2059167)
Tax period: 2015-01-01 to 2015-12-31
Filed: 2016-08-04
IRS object ID: 201632179349301248
Schema version: 2015v2.1
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule D
Schedule F
Schedule I
Schedule J
Schedule O
Schedule R

Return header ReturnHeader

Field	Value	IRS element (for citing)
Return	2016-08-04T15:22:28-05:00	ReturnTs
Tax Period End	2015-12-31	TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

Field	Value	IRS element (for citing)
Business Name Line1	KPMG LLP	BusinessNameLine1Txt

Preparer US Address PreparerUSAddress

Field	Value	IRS element (for citing)
Address Line1	1676 International Drive	AddressLine1Txt
City	McLean	CityNm
State Abbreviation	VA	StateAbbreviationCd
ZIP	22102	ZIPCd

Field	Value	IRS element (for citing)
Return Type	990	ReturnTypeCd
Tax Period Begin	2015-01-01	TaxPeriodBeginDt

Filer Filer

Field	Value	IRS element (for citing)
EIN	912059167	EIN

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
In Care Of	% PRESTON W CAMPBELL MD	InCareOfNm
Business Name Control	CYST	BusinessNameControlTxt
Phone	3019514422	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	6931 ARLINGTON ROAD Suite 200	AddressLine1Txt
City	BETHESDA	CityNm
State Abbreviation	MD	StateAbbreviationCd
ZIP	20814	ZIPCd

Business Officer BusinessOfficerGrp

Field	Value	IRS element (for citing)
Person	PRESTON W CAMPBELL MD	PersonNm
Person Title	PRESIDENT & CEO	PersonTitleTxt
Phone	3019514422	PhoneNum
Signature	2016-08-02	SignatureDt
Discuss With Paid Preparer	Yes (true)	DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

Field	Value	IRS element (for citing)
Preparer Person	JOCELYNE C MILLER	PreparerPersonNm
PTIN	P00634378	PTIN
Phone	7032868000	PhoneNum

Field	Value	IRS element (for citing)
Tax	2015	TaxYr
Build TS	2016-12-15 16:53:06Z	BuildTS

Form 990 IRS990

Field	Value	IRS element (for citing)
Principal Officer	PRESTON W CAMPBELL MD	PrincipalOfficerNm

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	6931 ARLINGTON ROAD STE 200	AddressLine1Txt
City	BETHESDA	CityNm
State Abbreviation	MD	StateAbbreviationCd
ZIP	20814	ZIPCd

Field	Value	IRS element (for citing)
Gross Receipts	$124,281,169	GrossReceiptsAmt
Group Return For Affiliates	false	GroupReturnForAffiliatesInd
Organization501c3	Yes (X)	Organization501c3Ind
Website Address	WWW.CFF.ORG/RESEARCH/CFFT/	WebsiteAddressTxt
Type Of Organization Corp	Yes (X)	TypeOfOrganizationCorpInd
Formation	2000	FormationYr
Legal Domicile State	MD	LegalDomicileStateCd
Activity Or Mission	THE MISSION IS TO CURE CYSTIC FIBROSIS AND TO PROVIDE ALL PEOPLE WITH THE DISEASE THE OPPORTUNITY TO LEAD FULL, PRODUCTIVE LIVES.	ActivityOrMissionDesc
Voting Members Governing Body	8	VotingMembersGoverningBodyCnt
Voting Members Independent	7	VotingMembersIndependentCnt
Total Employee	39	TotalEmployeeCnt
Total Volunteers	0	TotalVolunteersCnt
Total Gross UBI	$0	TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm	$0	NetUnrelatedBusTxblIncmAmt
PY Contributions Grants	$0	PYContributionsGrantsAmt
CY Contributions Grants	$86,230,120	CYContributionsGrantsAmt
PY Program Service Revenue	$3,274,846,429	PYProgramServiceRevenueAmt
CY Program Service Revenue	$120,217	CYProgramServiceRevenueAmt
PY Investment Income	$25,502	PYInvestmentIncomeAmt
CY Investment Income	$0	CYInvestmentIncomeAmt
PY Other Revenue	$9,066	PYOtherRevenueAmt
CY Other Revenue	$37,930,832	CYOtherRevenueAmt
PY Total Revenue	$3,274,880,997	PYTotalRevenueAmt
CY Total Revenue	$124,281,169	CYTotalRevenueAmt
PY Grants And Similar Paid	$3,231,024,082	PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid	$62,018,896	CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members	$0	PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members	$0	CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid	$6,801,253	PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid	$9,002,193	CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns	$0	PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns	$0	CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense	$0	CYTotalFundraisingExpenseAmt
PY Other Expenses	$37,055,662	PYOtherExpensesAmt
CY Other Expenses	$53,260,080	CYOtherExpensesAmt
PY Total Expenses	$3,274,880,997	PYTotalExpensesAmt
CY Total Expenses	$124,281,169	CYTotalExpensesAmt
CY Revenues Less Expenses	$0	CYRevenuesLessExpensesAmt
Total Assets BOY	$63,052,423	TotalAssetsBOYAmt
Total Assets EOY	$85,794,978	TotalAssetsEOYAmt
Total Liabilities BOY	$63,052,423	TotalLiabilitiesBOYAmt
Total Liabilities EOY	$85,794,978	TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY	$0	NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY	$0	NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part III	Yes (X)	InfoInScheduleOPartIIIInd
Mission	THE MISSION OF THE CYSTIC FIBROSIS FOUNDATION THERAPEUTICS IS TO CURE CYSTIC FIBROSIS AND TO PROVIDE ALL PEOPLE WITH THE DISEASE THE OPPORTUNITY TO LEAD FULL, PRODUCTIVE LIVES BY FUNDING RESEARCH AND DRUG DEVELOPMENT AND PROMOTING INDIVIDUALIZED TREATMENT. A LIFE-SHORTENING GENETIC DISEASE, CF AFFECTS THE LUNGS AND DIGESTIVE SYSTEMS OF MORE THAN 30,000 PEOPLE IN THE U.S. CURRENTLY, THERE IS NO CURE.	MissionDesc
Significant New Program Srvc	false	SignificantNewProgramSrvcInd
Significant Change	false	SignificantChangeInd
Expense	$56,638,070	ExpenseAmt
Desc	INVESTMENTS BY CYSTIC FIBROSIS FOUNDATION THERAPEUTICS (CFFT) IN STATE-OF-THE-ART RESEARCH HAVE ACCELERATED PROGRESS TOWARD DEVELOPING NEW CF TREATMENTS AND FINDING A CURE FOR THE DISEASE. BY FUNDING CF DRUG DISCOVERY AND DEVELOPMENT RESEARCH CONDUCTED BY BIOTECHNOLOGY COMPANIES AND PROVIDING MATCHING AWARDS TO CF DRUG DEVELOPERS FOR CF RESEARCH, AND WITH A SPECIALIZED CF CLINICAL TRIALS NETWORK, CFFT HAS ATTRACTED SIGNIFICANT INDUSTRY INVOLVEMENT IN THE FIGHT AGAINST CF. CFFT ACCOMPLISHES ITS MISSION BY FUNDING LIFE-SAVING RESEARCH TO DEVELOP EFFECTIVE THERAPIES FOR PEOPLE WITH CF. CFFT HAS FUNDED HUNDREDS OF MILLIONS OF DOLLARS OF RESEARCH COSTS TO HELP DEVELOP CF DRUGS AND THERAPIES. THROUGH CFFTS EFFORTS, THE LIFE EXPECTANCY OF PEOPLE WITH CF HAS DOUBLED IN THE LAST 30 YEARS, AND RESEARCH TO FIND A CURE IS MORE PROMISING THAN EVER BEFORE.	Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

Field	Value	IRS element (for citing)
Expense	$66,442,579	ExpenseAmt
Grant	$62,018,896	GrantAmt
Revenue	$120,217	RevenueAmt
Desc	CFFT SUPPORTS A NATIONAL CLINICAL RESEARCH NETWORK OF NEARLY 80 FOUNDATION-ACCREDITED CARE CENTERS THAT COLLABORATE TO CONDUCT CLINICAL TRIALS, ALLOWING POTENTIAL NEW CF THERAPIES TO MOVE TO LARGER, LATE-STAGE STUDIES MORE QUICKLY. MEDICAL PROGRAMS IN 2015 CONSISTED OF COSTS TO SUPPORT SCIENTIFIC STUDY AND INVESTIGATIONS. 507 GRANTS WERE AWARDED IN 2015.	Desc

Field	Value	IRS element (for citing)
Total Program Service Expenses	$123,080,649	TotalProgramServiceExpensesAmt
Described In Section501c3	Yes (true)	DescribedInSection501c3Ind
Schedule B Required	Yes (true)	ScheduleBRequiredInd
Political Campaign Acty	false	PoliticalCampaignActyInd
Lobbying Activities	false	LobbyingActivitiesInd
Subject To Proxy Tax	false	SubjectToProxyTaxInd
Donor Advised Fund	false	DonorAdvisedFundInd
Conservation Easements	false	ConservationEasementsInd
Collections Of Art	false	CollectionsOfArtInd
Credit Counseling	false	CreditCounselingInd
Temp Or Permanent Endowments	false	TempOrPermanentEndowmentsInd
Report Land Building Equipment	Yes (true)	ReportLandBuildingEquipmentInd
Report Investments Other Sec	false	ReportInvestmentsOtherSecInd
Report Program Related Invst	false	ReportProgramRelatedInvstInd
Report Other Assets	Yes (true)	ReportOtherAssetsInd
Report Other Liabilities	false	ReportOtherLiabilitiesInd
Include FIN48 Footnote	Yes (true)	IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt	false	IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt	Yes (true)	ConsolidatedAuditFinclStmtInd
School Operating	false	SchoolOperatingInd
Foreign Office	false	ForeignOfficeInd
Foreign Activities	Yes (true)	ForeignActivitiesInd
More Than5000 K To Org	Yes (true)	MoreThan5000KToOrgInd
More Than5000 K To Individuals	false	MoreThan5000KToIndividualsInd
Professional Fundraising	false	ProfessionalFundraisingInd
Fundraising Activities	false	FundraisingActivitiesInd
Gaming Activities	false	GamingActivitiesInd
Operate Hospital	false	OperateHospitalInd
Grants To Organizations	Yes (true)	GrantsToOrganizationsInd
Grants To Individuals	Yes (true)	GrantsToIndividualsInd
Schedule J Required	Yes (true)	ScheduleJRequiredInd
Tax Exempt Bonds	false	TaxExemptBondsInd
Engaged In Excess Benefit Trans	false	EngagedInExcessBenefitTransInd
PY Excess Benefit Trans	false	PYExcessBenefitTransInd
Loan Outstanding	false	LoanOutstandingInd
Grant To Related Person	false	GrantToRelatedPersonInd
Business Rln With Org Mem	false	BusinessRlnWithOrgMemInd
Business Rln With Fam Mem	false	BusinessRlnWithFamMemInd
Business Rln With Officer Ent	false	BusinessRlnWithOfficerEntInd
Deductible Non Cash Contri	false	DeductibleNonCashContriInd
Deductible Art Contribution	false	DeductibleArtContributionInd
Terminate Operations	false	TerminateOperationsInd
Partial Liquidation	false	PartialLiquidationInd
Disregarded Entity	false	DisregardedEntityInd
Related Entity	Yes (true)	RelatedEntityInd
Related Organization Ctrl Ent	false	RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org	false	TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp	false	ActivitiesConductedPrtshpInd
Schedule O Required	Yes (true)	ScheduleORequiredInd
IRP Document	97	IRPDocumentCnt
IRP Document W2 G	0	IRPDocumentW2GCnt
Backup Wthld Compliance	Yes (true)	BackupWthldComplianceInd
Employee	39	EmployeeCnt
Employment Tax Returns Filed	Yes (true)	EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit	false	UnrelatedBusIncmOverLimitInd
Foreign Financial Account	false	ForeignFinancialAccountInd
Prohibited Tax Shelter Trans	false	ProhibitedTaxShelterTransInd
Taxable Party Notification	false	TaxablePartyNotificationInd
Nondeductible Contributions	false	NondeductibleContributionsInd
Quid Pro Quo Contributions	false	QuidProQuoContributionsInd
Form8282 Property Disposed Of	false	Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct	false	RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct	false	PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services	false	IndoorTanningServicesInd
Info In Schedule O Part VI	Yes (X)	InfoInScheduleOPartVIInd
Governing Body Voting Members	8	GoverningBodyVotingMembersCnt
Independent Voting Member	7	IndependentVotingMemberCnt
Family Or Business Rln	false	FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties	false	DelegationOfMgmtDutiesInd
Change To Org Documents	false	ChangeToOrgDocumentsInd
Material Diversion Or Misuse	false	MaterialDiversionOrMisuseInd
Members Or Stockholders	false	MembersOrStockholdersInd
Election Of Board Members	Yes (true)	ElectionOfBoardMembersInd
Decisions Subject To Approva	false	DecisionsSubjectToApprovaInd
Minutes Of Governing Body	Yes (true)	MinutesOfGoverningBodyInd
Minutes Of Committees	Yes (true)	MinutesOfCommitteesInd
Officer Mailing Address	false	OfficerMailingAddressInd
Local Chapters	false	LocalChaptersInd
Form990 Provided To Gvrn Body	Yes (true)	Form990ProvidedToGvrnBodyInd
Conflict Of Interest Policy	Yes (true)	ConflictOfInterestPolicyInd
Annual Disclosure Covered Prsn	Yes (true)	AnnualDisclosureCoveredPrsnInd
Regular Monitoring Enfrc	Yes (true)	RegularMonitoringEnfrcInd
Whistleblower Policy	Yes (true)	WhistleblowerPolicyInd
Document Retention Policy	Yes (true)	DocumentRetentionPolicyInd
Compensation Process CEO	Yes (true)	CompensationProcessCEOInd
Compensation Process Other	Yes (true)	CompensationProcessOtherInd
Investment In Joint Venture	false	InvestmentInJointVentureInd
States Where Copy Of Return Is Fld	MI	StatesWhereCopyOfReturnIsFldCd
Own Website	Yes (X)	OwnWebsiteInd
Upon Request	Yes (X)	UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Field	Value	IRS element (for citing)
Person	PRESTON W CAMPBELL MD	PersonNm
Phone	3019514422	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	6931 ARLINGTON RD STE 200	AddressLine1Txt
City	BETHESDA	CityNm
State Abbreviation	MD	StateAbbreviationCd
ZIP	20814	ZIPCd

Field	Value	IRS element (for citing)
Info In Schedule O Part VII	Yes (X)	InfoInScheduleOPartVIIInd

Form990 Part VII Section A Form990PartVIISectionAGrp (16 entries)

TitleTitleTxt	Average Hours Per WeekAverageHoursPerWeekRt	Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt	Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd	Reportable Comp From OrgReportableCompFromOrgAmt	Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt	Other CompensationOtherCompensationAmt	OfficerOfficerInd	Highest Compensated EmployeeHighestCompensatedEmployeeInd
JASON M ARYEH
DIRECTOR	3.0	0.0	Yes (X)	$0	$0	$0
JONATHAN COHN MD
DIRECTOR	3.0	0.0	Yes (X)	$0	$0	$0
CATHERINE C MCLOUD
DIRECTOR	3.0	11.0	Yes (X)	$0	$0	$0
D PAUL FLESSNER
DIRECTOR	3.0	0.0	Yes (X)	$0	$0	$0
STEVEN SHAK MD
DIRECTOR	3.0	6.0	Yes (X)	$0	$0	$0
ERIC R OLSON PHD
DIRECTOR	3.0	0.0	Yes (X)	$0	$0	$0
THEODORE J TORPHY PHD
CHAIR	5.0	6.0	Yes (X)	$13,200	$0	$0
PRESTON CAMPBELL MD
PRESIDENT & CEO (AS OF 10/1)	20.0	40.0	Yes (X)	$245,571	$496,970	$212,541	Yes (X)
ROBERT BEALL PHD
PRESIDENT & CEO (UNTIL 9/30)	20.0	40.0	Yes (X)	$779,230	$1,575,208	$108,896	Yes (X)
C RICHARD MATTINGLY
EXECUTIVE VP & COO	5.0	55.0		$0	$2,718,373	$68,546	Yes (X)
VERA H TWIGG
EXECUTIVE VP, CFO & SECRETARY	5.0	55.0		$0	$499,672	$107,968	Yes (X)
BRUCE MARSHALL MD
SENIOR VP OF CLINICAL AFFAIRS	35.0	15.0		$314,135	$129,754	$32,060		Yes (X)
MICHAEL P BOYLE MD
SENIOR VP OF THERAPEUTICS DEV.	50.0	0.0		$268,355	$0	$14,595		Yes (X)
CHRIS PENLAND PHD
VICE PRESIDENT OF RESEARCH	23.0	27.0		$122,428	$139,512	$53,305		Yes (X)
WILLIAM SKACH MD
SENIOR VP OF RESEARCH AFFAIRS	38.0	12.0		$233,504	$74,887	$48,493		Yes (X)
DAVID MCLOUGHLIN
SR. VP OF OPERATIONS	35.0	15.0		$108,101	$253,478	$60,349		Yes (X)

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	$2,084,524	TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org	$5,887,854	TotReportableCompRltdOrgAmt
Total Other Compensation	$706,753	TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K	18	IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed	false	FormerOfcrEmployeesListedInd
Total Comp Greater Than150 K	Yes (true)	TotalCompGreaterThan150KInd
Compensation From Other Srcs	false	CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1Txt	CityContractorAddress/USAddress/CityNm	State AbbreviationContractorAddress/USAddress/StateAbbreviationCd	ZIPContractorAddress/USAddress/ZIPCd	ServicesServicesDesc	CompensationCompensationAmt	Address Line1ContractorAddress/ForeignAddress/AddressLine1Txt	CityContractorAddress/ForeignAddress/CityNm	Province Or StateContractorAddress/ForeignAddress/ProvinceOrStateNm	CountryContractorAddress/ForeignAddress/CountryCd
PFIZER INC
200 CAMBRIDGEPARK DRIVE	CAMBRIDGE	MA	02140	CONTRACTED RESEARCH	$13,724,392
GENZYME CORPORATION
FIVE MOUNTAIN ROAD	FRAMINGHAM	MA	01701	CONTRACTED RESEARCH	$5,856,680
SHIRE ORPHAN RARE DISEASE GMBH
				CONTRACTED RESEARCH	$4,987,500	ZAHLERWEG 10	ZUG	0	SZ
ALGIPHARMA AS
				CONTRACTED RESEARCH	$4,800,000	INDUSTRIVAN 33	SANOVINA	0	NO
ANTHERA PHARMACEUTICALS
25801 INDUSTRIAL BLVD	HAYWARD	CA	94545	CONTRACTED RESEARCH	$2,638,627

Field	Value	IRS element (for citing)
Cntrct Rcvd Greater Than100 K	26	CntrctRcvdGreaterThan100KCnt
Related Organizations	$86,230,120	RelatedOrganizationsAmt
All Other Contributions	$0	AllOtherContributionsAmt
Total Contributions	$86,230,120	TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp

Field	Value	IRS element (for citing)
Desc	CLINICAL STUDY	Desc
Business	541900	BusinessCd
Total Revenue Column	$120,217	TotalRevenueColumnAmt
Related Or Exempt Func Income	$120,217	RelatedOrExemptFuncIncomeAmt

Field	Value	IRS element (for citing)
Total Program Service Revenue	$120,217	TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Royalties Revenue RoyaltiesRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$31,822,208	TotalRevenueColumnAmt
Related Or Exempt Func Income	$31,822,208	RelatedOrExemptFuncIncomeAmt

Rental Income Or Loss RentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Real	$0	RealAmt
Personal	$0	PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Net Income From Gaming NetIncomeFromGamingGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Net Income Or Loss NetIncomeOrLossGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Other Revenue Misc OtherRevenueMiscGrp (2 entries)

DescDesc	BusinessBusinessCd	Total Revenue ColumnTotalRevenueColumnAmt	Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt
REFUNDED OR CANCELLED GRANT	900099	$5,908,624	$5,908,624
MISCELLANEOUS INCOME	900099	$200,000	$200,000

Field	Value	IRS element (for citing)
Other Revenue Total	$6,108,624	OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$124,281,169	TotalRevenueColumnAmt
Related Or Exempt Func Income	$38,051,049	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	$0	ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

Field	Value	IRS element (for citing)
Total	$55,715,621	TotalAmt
Program Services	$55,715,621	ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

Field	Value	IRS element (for citing)
Total	$7,000	TotalAmt
Program Services	$7,000	ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

Field	Value	IRS element (for citing)
Total	$6,296,275	TotalAmt
Program Services	$6,296,275	ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

Field	Value	IRS element (for citing)
Total	$1,109,667	TotalAmt
Program Services	$1,012,768	ProgramServicesAmt
Management And General	$96,899	ManagementAndGeneralAmt

Comp Disqual Persons CompDisqualPersonsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

Field	Value	IRS element (for citing)
Total	$6,740,789	TotalAmt
Program Services	$6,152,165	ProgramServicesAmt
Management And General	$588,624	ManagementAndGeneralAmt

Pension Plan Contributions PensionPlanContributionsGrp

Field	Value	IRS element (for citing)
Total	$268,819	TotalAmt
Program Services	$245,345	ProgramServicesAmt
Management And General	$23,474	ManagementAndGeneralAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

Field	Value	IRS element (for citing)
Total	$423,586	TotalAmt
Program Services	$386,597	ProgramServicesAmt
Management And General	$36,989	ManagementAndGeneralAmt

Payroll Taxes PayrollTaxesGrp

Field	Value	IRS element (for citing)
Total	$459,332	TotalAmt
Program Services	$413,720	ProgramServicesAmt
Management And General	$45,612	ManagementAndGeneralAmt

Fees For Services Management FeesForServicesManagementGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

Field	Value	IRS element (for citing)
Total	$604,718	TotalAmt
Program Services	$604,718	ProgramServicesAmt

Fees For Services Accounting FeesForServicesAccountingGrp

Field	Value	IRS element (for citing)
Total	$3,990	TotalAmt
Management And General	$3,990	ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Fees For Services Other FeesForServicesOtherGrp

Field	Value	IRS element (for citing)
Total	$276,438	TotalAmt
Program Services	$223,242	ProgramServicesAmt
Management And General	$53,196	ManagementAndGeneralAmt

Advertising AdvertisingGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Office Expenses OfficeExpensesGrp

Field	Value	IRS element (for citing)
Total	$1,091,426	TotalAmt
Program Services	$975,603	ProgramServicesAmt
Management And General	$115,823	ManagementAndGeneralAmt

Information Technology InformationTechnologyGrp

Field	Value	IRS element (for citing)
Total	$882,625	TotalAmt
Program Services	$782,729	ProgramServicesAmt
Management And General	$99,896	ManagementAndGeneralAmt

Royalties RoyaltiesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Occupancy OccupancyGrp

Field	Value	IRS element (for citing)
Total	$1,051,598	TotalAmt
Program Services	$995,202	ProgramServicesAmt
Management And General	$56,396	ManagementAndGeneralAmt

Travel TravelGrp

Field	Value	IRS element (for citing)
Total	$274,593	TotalAmt
Program Services	$257,848	ProgramServicesAmt
Management And General	$16,745	ManagementAndGeneralAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Conferences Meetings ConferencesMeetingsGrp

Field	Value	IRS element (for citing)
Total	$439,323	TotalAmt
Program Services	$416,520	ProgramServicesAmt
Management And General	$22,803	ManagementAndGeneralAmt

Interest InterestGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Payments To Affiliates PaymentsToAffiliatesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Depreciation Depletion DepreciationDepletionGrp

Field	Value	IRS element (for citing)
Total	$466,409	TotalAmt
Program Services	$450,668	ProgramServicesAmt
Management And General	$15,741	ManagementAndGeneralAmt

Insurance InsuranceGrp

Field	Value	IRS element (for citing)
Total	$324,275	TotalAmt
Program Services	$324,275	ProgramServicesAmt

Other Expenses OtherExpensesGrp (3 entries)

DescDesc	TotalTotalAmt	Program ServicesProgramServicesAmt	Management And GeneralManagementAndGeneralAmt
CONTRACTED RESEARCH	$46,960,119	$46,960,119
MEDICAL ADVISORY FEES	$497,387	$497,387
MISCELLANEOUS	$387,179	$362,847	$24,332

Total Functional Expenses TotalFunctionalExpensesGrp

Field	Value	IRS element (for citing)
Total	$124,281,169	TotalAmt
Program Services	$123,080,649	ProgramServicesAmt
Management And General	$1,200,520	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

Field	Value	IRS element (for citing)
BOY	$2,026,003	BOYAmt
EOY	-$3,060,639	EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Accounts Receivable AccountsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$261,700	BOYAmt
EOY	$28,485,525	EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

Field	Value	IRS element (for citing)
BOY	$404,036	BOYAmt
EOY	$577,130	EOYAmt

Field	Value	IRS element (for citing)
Land Bldg Equip Cost Or Other Bss	$2,534,959	LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec	$1,137,407	LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

Field	Value	IRS element (for citing)
BOY	$934,327	BOYAmt
EOY	$1,397,552	EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Intangible Assets IntangibleAssetsGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Other Assets Total OtherAssetsTotalGrp

Field	Value	IRS element (for citing)
BOY	$59,426,357	BOYAmt
EOY	$58,395,410	EOYAmt

Total Assets TotalAssetsGrp

Field	Value	IRS element (for citing)
BOY	$63,052,423	BOYAmt
EOY	$85,794,978	EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

Field	Value	IRS element (for citing)
BOY	$1,129,462	BOYAmt
EOY	$2,971,343	EOYAmt

Grants Payable GrantsPayableGrp

Field	Value	IRS element (for citing)
BOY	$61,922,961	BOYAmt
EOY	$82,823,635	EOYAmt

Deferred Revenue DeferredRevenueGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Other Liabilities OtherLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Total Liabilities TotalLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$63,052,423	BOYAmt
EOY	$85,794,978	EOYAmt

Field	Value	IRS element (for citing)
Organization Follows SFAS117	Yes (X)	OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$63,052,423	BOYAmt
EOY	$85,794,978	EOYAmt

Field	Value	IRS element (for citing)
Reconcilation Revenue Expnss	$0	ReconcilationRevenueExpnssAmt
Method Of Accounting Accrual	Yes (X)	MethodOfAccountingAccrualInd
Accountant Compile Or Review	false	AccountantCompileOrReviewInd
FS Audited	Yes (true)	FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

Field	Value	IRS element (for citing)
Consolidated Basis Fincl Stmt	Yes (X)	ConsolidatedBasisFinclStmtInd

Field	Value	IRS element (for citing)
Audit Committee	Yes (true)	AuditCommitteeInd
Federal Grant Audit Required	false	FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Supporting Organization509a3	Yes (X)	SupportingOrganization509a3Ind
Supporting Org Type1	Yes (X)	SupportingOrgType1Ind
Supported Organizations	118	SupportedOrganizationsCnt

Supported Org Information SupportedOrgInformationGrp (119 entries)

EINEIN	Organization TypeOrganizationTypeCd	Governing Document ListedGoverningDocumentListedInd	SupportSupportAmt	Other SupportOtherSupportAmt
CYSTIC FIBROSIS FOUNDATION
131930701	7	Yes (true)	$0	$0
ALBANY MEDICAL COLLEGE
141338310	2	false	$174,236	$0
ALL CHILDREN'S HOSPITAL
590683252	3	false	$242,316	$0
ANN AND ROBERT H LURIE CHILDREN'S HOSPITAL OF CHI
363357006	7	false	$422,279	$0
ARIZONA BOARD OF REGENTS UNIVERSITY OF ARIZONA
742652689	6	false	$674,659	$0
ATLANTIC HEALTH SYSTEM
521958352	3	false	$326,345	$0
BAYLOR COLLEGE OF MEDICINE
741613878	2	false	$446,113	$0
BETH ISRAEL MEDICAL CENTER
135564934	3	false	$268,845	$0
BOARD OF REGENTS OF THE UNIVERSITY OF WISCONSIN SY
396006492	6	false	$718,674	$0
BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UN
941156365	2	false	$555,836	$0
CASE WESTERN RESERVE UNIVERSITY
341018992	2	false	$1,807,928	$0
CEDARS-SINAI MEDICAL CENTER
951644600	3	false	$162,000	$0
CHILDREN'S HEALTH CARE
411754276	3	false	$174,340	$0
CHILDREN'S HOSPITAL CORPORATION (BOSTON CHILDREN'S
042774441	3	false	$961,223	$0
CHILDREN'S HOSPITAL MEDICAL CENTER
310833936	3	false	$1,758,844	$0
CHILDREN'S HOSPITAL MEDICAL CENTER OF AKRON
340714357	3	false	$89,662	$0
CHILDREN'S HOSPITAL LOS ANGELES
951690977	3	false	$148,296	$0
CHILDREN'S MEDICAL CENTER
310672132	3	false	$158,148	$0
CONNECTICUT CHILDREN'S MEDICAL CENTER
060646755	3	false	$67,669	$0
COOK CHILDREN'S MEDICAL CENTER
752051646	3	false	$270,377	$0
DANA-FARBER CANCER INSTITUTE
042263040	7	false	$162,000	$0
PHILADELPHIA HEALTH & EDUCATION CORPORATION
232979433	2	false	$93,186	$0
EMORY UNIVERSITY
580566256	2	false	$936,561	$0
GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTIT
581418202	7	false	$116,053	$0
GEORGIA INSTITUTE OF TECHNOLOGY
586002023	6	false	$264,611	$0
KAISER FOUNDATION RESEARCH INSTITUTE
941105628	3	false	$217,527	$0
LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER
726087770	6	false	$162,000	$0
MAINE MEDICAL CENTER
010238552	3	false	$140,292	$0
MEDICAL UNIVERSITY OF SOUTH CAROLINA
576000722	6	false	$239,349	$0
MEMORIAL CHILDREN'S HOSPITAL
953527031	3	false	$300,657	$0
MEMORIAL SLOAN KETTERING CANCER CENTER
131924236	3	false	$54,097	$0
MONMOUTH MEDICAL CENTER FOUNDATION
222456079	7	false	$72,203	$0
NATIONAL JEWISH MEDICAL AND RESEARCH CENTER
742044647	3	false	$610,128	$0
NEMOURS CHILDREN'S CLINIC ORLANDO
590634433	3	false	$127,526	$0
NORTHWESTERN UNIVERSITY
362167817	2	false	$157,181	$0
OREGON HEALTH & SCIENCE UNIVERSITY
237083114	5	false	$738,950	$0
OSF SAINT FRANCIS MEDICAL CENTER
370662569	3	false	$83,238	$0
PENNSYLVANIA STATE UNIVERSITY
246000376	6	false	$111,433	$0
PROVIDENCE ALASKA MEDICAL CENTER
920016429	3	false	$70,040	$0
REGENTS OF THE UNIVERSITY OF COLORADO AT DENVER
846000555	2	false	$1,570,331	$0
THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW
141368361	7	false	$566,170	$0
RUTGERS THE STATE UNIVERSITY OF NEW JERSEY
462354111	6	false	$181,062	$0
SANFORD CHILDRENS SPECIALITY CLINIC
460447693	3	false	$181,290	$0
SEATTLE CHILDREN'S HOSPITAL
910564748	3	false	$14,381,231	$0
SETON HEALTHCARE DELL CHILDREN'S
741109643	3	false	$163,609	$0
SPECTRUM HEALTH FOUNDATION
382752328	7	false	$156,618	$0
ST LOUIS UNIVERSITY
430654872	2	false	$168,935	$0
ST LUKE'S REGIONAL MEDICAL CENTER
820161600	3	false	$101,594	$0
TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER
752668014	6	false	$164,866	$0
THE CHILDREN'S HOSPITAL OF PHILADELPHIA
231352166	3	false	$273,763	$0
THE CHILDREN'S MERCY HOSPITAL
440605373	3	false	$259,627	$0
THE CURATORS OF THE UNIVERSITY OF MISSOURI
436003859	6	false	$22,156	$0
THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
112673595	4	false	$173,140	$0
THE GENERAL HOSPITAL CORPORATION (MASSACHUSETTS GE
042697983	3	false	$386,448	$0
THE HITCHCOCK FOUNDATION
020222139	7	false	$332,360	$0
THE JOHNS HOPKINS UNIVERSITY
520595110	2	false	$2,749,060	$0
THE MEDICAL COLLEGE OF WISCONSIN
390806261	2	false	$232,145	$0
THE RECTOR AND VISITORS OF THE UNIVERSITY OF VIRGI
546001796	2	false	$166,460	$0
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN D
956006144	2	false	$492,690	$0
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
386006309	2	false	$887,567	$0
THE REGENTS OF THE UNIVERSITY OF MINNESOTA
416007513	6	false	$430,425	$0
THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HO
316056230	4	false	$532,249	$0
THE SCRIPPS RESEARCH INSTITUTE
330435954	4	false	$193,350	$0
THE TOLEDO HOSPITAL
344428256	3	false	$126,510	$0
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF
135598093	2	false	$615,484	$0
THE UNIVERSITY OF ALABAMA AT BIRMINGHAM
636005396	2	false	$1,876,851	$0
THE UNIVERSITY OF CHICAGO
362177139	2	false	$26,061	$0
THE UNIVERSITY OF IOWA
426004813	6	false	$2,458,340	$0
THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
566001393	2	false	$2,063,278	$0
THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT H
741761309	6	false	$380,000	$0
THE UNIVERSITY OF UTAH
876000525	2	false	$766,526	$0
THE UNIVERSITY OF VERMONT AND STATE AGRICULTURAL C
030179440	2	false	$297,424	$0
TRUSTEES OF BOSTON UNIVERSITY
042103547	2	false	$81,000	$0
TRUSTEES OF INDIANA UNIVERSITY
356001673	2	false	$382,742	$0
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
231352685	2	false	$55,102	$0
UNIVERSITY AT BUFFALO PEDIATRIC ASSOCIATES
161238821	9	false	$12,636	$0
UNIVERSITY OF ALABAMA IN HUNTSVILLE
630520830	2	false	$145,126	$0
UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES
716046242	6	false	$98,960	$0
UNIVERSITY OF CINCINNATI PHYSICIANS COMPANY
311435820	9	false	$153,539	$0
UNIVERSITY OF COLORADO HEALTH SCIENCES CENTER
846000555	2	false	$856,012	$0
UNIVERSITY OF FLORIDA
596002052	6	false	$243,845	$0
UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
043167352	6	false	$182,322	$0
UNIVERSITY OF MIAMI
590624458	2	false	$216,505	$0
UNIVERSITY OF NEBRASKA MEDICAL CENTER
470491233	2	false	$210,962	$0
UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER
736017987	6	false	$173,593	$0
UNIVERSITY OF PITTSBURGH
250965591	2	false	$1,356,500	$0
UNIVERSITY OF ROCHESTER
160743209	2	false	$278,705	$0
UNIVERSITY OF SOUTHERN CALIFORNIA
951642394	2	false	$451,711	$0
UNIVERSITY OF TENNESSEE
626001636	6	false	$78,027	$0
UNIVERSITY OF WASHINGTON
916001537	6	false	$554,492	$0
UT SOUTHWESTERN MEDICAL CENTER AT DALLAS
756002868	6	false	$921,460	$0
VANDERBILT UNIVERSITY
620476822	2	false	$109,021	$0
VIA CHRISTI REGIONAL MEDICAL CENTER INC
481172106	3	false	$65,991	$0
VIRGINIA COMMONWEALTH UNIVERSITY
546001758	6	false	$363,557	$0
WAKE FOREST UNIVERSITY HEALTH SCIENCES
223849199	2	false	$61,280	$0
WASHINGTON UNIVERSITY
430653611	2	false	$354,752	$0
WAYNE STATE UNIVERSITY
383028425	2	false	$335,704	$0
WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY
150532082	2	false	$162,000	$0
YALE UNIVERSITY
060646973	2	false	$341,822	$0
AZIENDA OSPEDALIERA UNIVERSITERIA
999999999	2	false	$60,000	$0
BAR-ILAN UNIVERSITY
999999999	2	false	$82,998	$0
ERASMUS MC
999999999	2	false	$901,894	$0
FOUNDATION OF THE FACULTY OF SCIENCES OF THE UNIVERSITY OF L
999999999	2	false	$277,130	$0
GOTEBORGS UNIVERSITET CFFT
999999999	2	false	$116,640	$0
HEBREW UNIVERSITY OF JERUSALEM
999999999	2	false	$162,000	$0
INSTITUTE OF CHILD HEALTH UNIVERSITY COLLEGE LONDON
999999999	2	false	$147,828	$0
MCGILL UNIVERSITY
999999999	2	false	$262,660	$0
QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE
999999999	4	false	$107,824	$0
ROYAL COLLEGE OF SURGEONS IN IRELAND
999999999	2	false	$162,000	$0
SIMON FRASER UNIVERSITY
999999999	2	false	$50,000	$0
ST MICHAEL'S HOSPITAL UNIVERSITY OF TORONTO
999999999	2	false	$91,319	$0
THE HOSPITAL FOR SICK CHILDREN
999999999	3	false	$790,714	$0
THE UNIVERSITY OF CAMBRIDGE
999999999	2	false	$162,000	$0
THE UNIVERSITY OF WESTERN AUSTRALIA
999999999	2	false	$2,107,172	$0
UNIVERSITY COLLEGE CORK
999999999	2	false	$51,247	$0
UNIVERSITY HOSPITAL HEIDELBERG
999999999	2	false	$79,065	$0
UNIVERSITY OF BRITISH COLUMBIA
999999999	2	false	$88,938	$0
UNIVERSITY OF MANCHESTER
999999999	2	false	$247,156	$0
UTRECHT UNIVERSITY
999999999	2	false	$347,690	$0

Field	Value	IRS element (for citing)
Supported Organizations Total	119	SupportedOrganizationsTotalCnt
Support Sum	$62,006,083	SupportSumAmt
Other Support Sum	$0	OtherSupportSumAmt

Form990 Sch A Supporting Org Form990SchASupportingOrgGrp

Field	Value	IRS element (for citing)
Listed By Name Governing Doc	false	ListedByNameGoverningDocInd
Suprt Org No IRS Determination	Yes (true)	SuprtOrgNoIRSDeterminationInd
Supported Org Section C456	false	SupportedOrgSectionC456Ind
Supported Org Not Organized US	Yes (true)	SupportedOrgNotOrganizedUSInd
Control Deciding Grnt Frgn Org	false	ControlDecidingGrntFrgnOrgInd
Support Foreign Org No Determ	Yes (true)	SupportForeignOrgNoDetermInd
Organization Change Suprt Org	false	OrganizationChangeSuprtOrgInd
Supported Org Class Designated	false	SupportedOrgClassDesignatedInd
Support Non Supported Org	false	SupportNonSupportedOrgInd
Payment Substantial Contribtr	false	PaymentSubstantialContribtrInd
Loan Disqualified Person	false	LoanDisqualifiedPersonInd
Controlled Disqualified Prsn	false	ControlledDisqualifiedPrsnInd
Disqualified Prsn Controll Int	false	DisqualifiedPrsnControllIntInd
Disqualified Prsn Ownr Int	false	DisqualifiedPrsnOwnrIntInd
Excess Business Holdings Rules	false	ExcessBusinessHoldingsRulesInd
Contribution Controller	false	ContributionControllerInd
Contribution Family	false	ContributionFamilyInd
Contribution35 Controlled	false	Contribution35ControlledInd

Form990 Sch A Type1 Suprt Org Form990SchAType1SuprtOrgGrp

Field	Value	IRS element (for citing)
Power Appoint Majority Dir Trst	Yes (true)	PowerAppointMajorityDirTrstInd
Operate Benefit Non Suprt Org	Yes (true)	OperateBenefitNonSuprtOrgInd

Form990 Schedule A Part VI Form990ScheduleAPartVIGrp

Field	Value	IRS element (for citing)
Form And Line Reference	SUPPORTED ORGANIZATIONS	FormAndLineReferenceDesc
Explanation	SCHEDULE A, PART I, LINE 11G All support provided by Cystic Fibrosis Foundation Therapeutics and reported in column (v) is for the benefit of Cystic Fibrosis Foundation, its supported organization. The support provided to the organizations listed in column (i) funds research critical to furthering the mission of the Cystic Fibrosis Foundation. SCHEDULE A, PART IV, LINE 1 CYSTIC FIBROSIS FOUNDATION IS THE ONLY SUPPORTED ORGANIZATION LISTED BY NAME IN THE GOVERNING DOCUMENTS OF CFFT. ALL OTHER SUPPORTED ORGANIZATIONS ARE DESIGNATED BY THE PURPOSE FOR WHICH THEY APPLY FOR SUPPORT FROM CFFT. ALL SUPPORT IS GIVEN FOR THE PURPOSE OF FUNDING RESEARCH INTO DRUG DEVELOPMENT FOR THE TREATMENT AND CURE OF CYSTIC FIBROSIS. CONTINUED SUPPORT TO ALL ORGANIZATIONS NOT NAMED IN THE GOVERNING DOCUMENTS IS CONTINGENT UPON THE ORGANIZATION DEMONSTRATING SCIENTIFIC PROGRESS. SCHEDULE A, PART IV, LINE 2 SUPPORTED ORGANIZATIONS WHO HAVE NOT RECEIVED AN IRS DETERMINATION LETTER ARE EITHER STATE GOVERNMENTAL UNITS DESCRIBED IN SECTION 170(B)(1)(a)(V) AND TAX EXEMPT UNDER IRC 115 OR ORGANIZATIONS OUTSIDE OF THE U.S. CFFT RECEIVES FROM ALL AWARD RECIPIENTS A W-8 OR W-9 AND A LETTER CERTIFYING THEIR STATUS AS A PUBLICALLY SUPPORTED ORGANIZATION EQUIVALENT TO 509(a)(1) OR 509(a)(2) EITHER WITHIN THE U.S. OR THEIR COUNTRY. SCHEDULE A, PART IV, LINE 4B CYSTIC FIBROSIS FOUNDATION, A SUPPORTED ORGANIZATION, HAD ULTIMATE CONTROL AND DISCRECTION IN DECIDING TO MAKE GRANTS TO FOREIGN SUPPORTED ORGANIZATIONS. SCHEDULE A, PART IV, LINE 4C CFFT RECEIVES FROM ALL FOREIGN SUPPORTED ORGANIZATIONS A W-8 AND A LETTER CERTIFYING THEIR STATUS AS A PUBLICALLY SUPPORTED ORGANIZATION EQUIVALENT TO 509(a)(1) OR 509(a)(2) WITHIN THEIR COUNTRY. FOR THE FULL MONITORING PROCESS OF AWARDS MADE TO FOREIGN SUPPORTED ORGANIZATIONS SEE SCHEDULE F, PART V. SCHEDULE A, PART IV, SECTION B, LINE 2 SEE NARRATIVE FOR SCHEDULE A, PART I, LINE 11G ABOVE.	ExplanationTxt

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

Field	Value	IRS element (for citing)
Contributor	RESTRICTED	ContributorNum

Contributor Business Name ContributorBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	RESTRICTED	BusinessNameLine1

Contributor US Address ContributorUSAddress

Field	Value	IRS element (for citing)
Address Line1	RESTRICTED	AddressLine1
Address Line2	RESTRICTED	AddressLine2
City	RESTRICTED	City
State	RESTRICTED	State
ZIP Code	RESTRICTED	ZIPCode

Field	Value	IRS element (for citing)
Total Contributions	RESTRICTED	TotalContributionsAmt

Schedule D IRS990ScheduleD

Field	Value	IRS element (for citing)
Art Public Exhibition Amounts		ArtPublicExhibitionAmountsGrp
Held Works Art		HeldWorksArtGrp
CY Minus3 Yr Endwmt Fund		CYMinus3YrEndwmtFundGrp
CY Minus4 Yr Endwmt Fund		CYMinus4YrEndwmtFundGrp
Land		LandGrp
Buildings		BuildingsGrp

Leasehold Improvements LeaseholdImprovementsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$4,914	OtherCostOrOtherBasisAmt
Depreciation	$4,914	DepreciationAmt
Book Value	$0	BookValueAmt

Equipment EquipmentGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$2,530,045	OtherCostOrOtherBasisAmt
Depreciation	$132,493	DepreciationAmt
Book Value	$1,397,552	BookValueAmt

Field	Value	IRS element (for citing)
Other Land Buildings		OtherLandBuildingsGrp
Total Book Value Land Buildings	$1,397,552	TotalBookValueLandBuildingsAmt

Other Assets Org OtherAssetsOrgGrp

Field	Value	IRS element (for citing)
Desc	INTERCOMPANY RECEIVABLE	Desc
Book Value	$58,395,410	BookValueAmt

Field	Value	IRS element (for citing)
Total Book Value Other Assets	$58,395,410	TotalBookValueOtherAssetsAmt
Federal Income Tax Liability	$0	FederalIncomeTaxLiabilityAmt
Total Liability	$0	TotalLiabilityAmt
Footnote Text	Yes (X)	FootnoteTextInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	SCHEDULE D, PART X	FormAndLineReferenceDesc
Explanation	FIN 48 FOOTNOTE THE FOUNDATION, CFFT, AND CFPAF ARE NOT-FOR-PROFIT VOLUNTARY HEALTH ORGANIZATIONS EXEMPT FROM FEDERAL INCOME TAXES UNDER 501(C)(3) OF THE INTERNAL REVENUE CODE (THE CODE) AND FROM STATE TAXES AND HAVE BEEN CLASSIFIED AS ORGANIZATIONS THAT ARE NOT PRIVATE FOUNDATIONS UNDER SECTION 509(A) OF THE CODE. THE FOUNDATION DOES NOT HAVE ANY UNRELATED BUSINESS INCOME TAX LIABILITY AS OF DECEMBER 31, 2015 AND 2014. CONTRIBUTIONS TO THE FOUNDATION QUALIFY FOR THE CHARITABLE CONTRIBUTIONS DEDUCTION TO THE EXTENT PROVIDED BY SECTION 170 OF THE CODE. CFPAF IS ORGANIZED AS A SINGLE MEMBER LIMITED LIABILITY COMPANY THAT IS A DISREGARDED ENTITY FOR FEDERAL TAX PURPOSES. THE SOLE MEMBER OF CFPAF IS THE FOUNDATION. THE FOUNDATION IS NOT AWARE OF ANY TAX POSITION TAKEN THAT REQUIRES DISCLOSURE BASED ON CURRENT FACTS AND CIRCUMSTANCES. THE FOUNDATION ANNUALLY REVIEWS ITS TAX POSITIONS AND HAS DETERMINED THAT THERE ARE NO MATERIAL UNCERTAIN TAX POSITIONS THAT REQUIRE RECOGNITION OR DISCLOSURE IN THE FINANCIAL STATEMENTS.	ExplanationTxt

Schedule F IRS990ScheduleF

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (true)	GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (5 entries)

RegionRegionTxt	Type Of Activities ConductedTypeOfActivitiesConductedTxt	Specific Services ProvidedSpecificServicesProvidedTxt	Region Total ExpendituresRegionTotalExpendituresAmt
North America	Grantmaking	NONE	$1,283,631
Europe (Including Iceland and Greenland)	Grantmaking	NONE	$2,660,474
East Asia and the Pacific	Grantmaking	NONE	$2,107,172
Middle East and North Africa	Grantmaking	NONE	$244,998
Europe (Including Iceland and Greenland)	Program Services	CONTRACTED RESEARCH	$11,775,000

Field	Value	IRS element (for citing)
Subtotal Spent	$18,071,275	SubtotalSpentAmt
Total Spent	$18,071,275	TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (26 entries)

RegionRegionTxt	Purpose Of GrantPurposeOfGrantTxt	Cash GrantCashGrantAmt	Manner Of Cash DisbursementMannerOfCashDisbursementTxt
North America	CLINICAL RESEARCH	$91,319	CHECK
North America	CLINICAL RESEARCH	$107,509	CHECK
North America	CLINICAL RESEARCH	$25,914	CHECK
North America	DRUG DISCOVERY	$262,660	CHECK
North America	DRUG DISCOVERY	$657,291	CHECK
North America	DRUG DISCOVERY	$50,000	CHECK
North America	DRUG DISCOVERY	$88,938	CHECK
Europe (Including Iceland and Greenland)	DRUG DISCOVERY	$277,130	WIRE
Europe (Including Iceland and Greenland)	DRUG DISCOVERY	$347,690	WIRE
Europe (Including Iceland and Greenland)	DRUG DISCOVERY	$195,806	WIRE
Europe (Including Iceland and Greenland)	DRUG DISCOVERY	$162,000	WIRE
Europe (Including Iceland and Greenland)	DRUG DISCOVERY	$79,065	WIRE
Europe (Including Iceland and Greenland)	DRUG DISCOVERY	$116,640	WIRE
Europe (Including Iceland and Greenland)	DRUG DISCOVERY	$51,247	WIRE
Europe (Including Iceland and Greenland)	DRUG DISCOVERY	$147,828	WIRE
Europe (Including Iceland and Greenland)	DRUG DISCOVERY	$51,350	WIRE
Europe (Including Iceland and Greenland)	DRUG DISCOVERY	$162,000	WIRE
Europe (Including Iceland and Greenland)	CLINICAL RESEARCH	$779,190	WIRE
Europe (Including Iceland and Greenland)	CLINICAL RESEARCH	$60,000	WIRE
Europe (Including Iceland and Greenland)	DRUG DISCOVERY	$107,824	WIRE
Europe (Including Iceland and Greenland)	CLINICAL RESEARCH	$122,704	WIRE
East Asia and the Pacific	DRUG DISCOVERY	$162,000	WIRE
East Asia and the Pacific	CLINICAL RESEARCH	$1,321,044	WIRE
East Asia and the Pacific	CLINICAL RESEARCH	$624,128	WIRE
Middle East and North Africa	DRUG DISCOVERY	$162,000	WIRE
Middle East and North Africa	DRUG DISCOVERY	$82,998	WIRE

Field	Value	IRS element (for citing)
Total501c3 Org	20	Total501c3OrgCnt
Transfer To Foreign Corp	false	TransferToForeignCorpInd
Interest In Foreign Trust	false	InterestInForeignTrustInd
Foreign Corp Ownership	false	ForeignCorpOwnershipInd
Passive Foreign Investmest Co	false	PassiveForeignInvestmestCoInd
Foreign Partnership	false	ForeignPartnershipInd
Boycott Countries	false	BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PROCEDURES FOR MONITORING GRANT FUNDS OUTSIDE OF THE U.S.	FormAndLineReferenceDesc
Explanation	SCHEDULE F, PART I, LINE 2 THE ORGANIZATION HAS PROCEDURES IN PLACE TO MONITOR THE SCIENTIFIC PROGRESS AND FINANCIAL ASPECTS OF GRANTS AWARDED TO ENTITIES OUTSIDE OF THE UNITED STATES. THE ORGANIZATION FOLLOWS THE U.S. DEPARTMENT OF TREASURY ANTI-TERRORIST FINANCING VOLUNTARY BEST PRACTICES GUIDELINES FOR CHARITIES. IN COMPLIANCE WITH THE BEST PRACTICES, THE ORGANIZATION COLLECTS AND REVIEWS INFORMATION ABOUT THE PROSPECTIVE GRANTEES AND CONDUCTS A VETTING PROCESS TO ENSURE THEY ARE NOT SUSPECTED OF ACTIVITIES RELATED TO TERRORISM. ONCE A GRANT IS APPROVED, A WRITTEN AGREEMENT IS SIGNED BY BOTH THE ORGANIZATION AND THE GRANTEE. FUNDING IS INCREMENTAL AND SPONSORED INSTITUTIONS ARE REQUIRED TO SUBMIT ANNUAL REPORTS OF EXPENDITURES AS WELL AS SCIENTIFIC PROGRESS REPORTS. SCIENTIFIC REPORTS ARE REVIEWED BY THE ORGANIZATION'S SCIENTIFIC STAFF TO DETERMINE PROGRESS. THE FINAL GRANT PAYMENT IS CONTINGENT UPON RECEIPT AND APPROVAL OF THE REPORT OF EXPENDITURES. REPORTS OF EXPENDITURES ARE REVIEWED AND APPROVED BY STAFF TO ENSURE INCURRED COSTS ARE APPROPRIATE. THE CF FOUNDATION'S INTERNAL AUDITORS CONDUCT AUDITS ON SAMPLES OF GRANT EXPENDITURE REPORTS BY EXAMINING SUPPORTING RECORDS FROM THE SPONSORED INSTITUTIONS. THE GRANTS IN THE MIDDLE EAST/NORTH AFRICA REGION WERE MADE TO BAR-ILAN UNIVERSITY AND HEBREW UNIVERSITY OF JERUSALEM, UNIVERSITIES IN ISRAEL.	ExplanationTxt

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (true)	GrantRecordsMaintainedInd

Recipient Table RecipientTable (182 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	Recipient EINRecipientEIN	IRC SectionIRCSectionDesc	Cash GrantCashGrantAmt	Purpose Of GrantPurposeOfGrantTxt
ALBANY MEDICAL COLLEGE
47 NEW SCOTLAND AVE	ALBANY	NY	12208	141338310	501C(3)	$174,236	CLINICAL RESEARCH CENTER
ALL CHILDREN'S HOSPITAL
DEPT 9010	ST PETERSBURG	FL	33731	590683252	501C(3)	$242,316	CLINICAL RESEARCH CENTER
ANN AND ROBERT H LURIE CHILDREN'S HOSPITAL OF CHI
2300 CHILDRENS PLAZA	CHICAGO	IL	60614	363357006	501C(3)	$39,279	CLINICAL RESEARCH
ANN AND ROBERT H LURIE CHILDREN'S HOSPITAL OF CHI
2300 CHILDRENS PLAZA	CHICAGO	IL	60614	363357006	501C(3)	$203,469	CLINICAL RESEARCH CENTER
ANN AND ROBERT H LURIE CHILDREN'S HOSPITAL OF CHI
2300 CHILDRENS PLAZA	CHICAGO	IL	60614	363357006	501C(3)	$17,531	CLINICAL RESEARCH STUDY
ANN AND ROBERT H LURIE CHILDREN'S HOSPITAL OF CHI
2300 CHILDRENS PLAZA	CHICAGO	IL	60614	363357006	501C(3)	$162,000	THERAPEUTICS DISCOVERY RESEARCH
ARIZONA BOARD OF REGENTS UNIVERSITY OF ARIZONA
888 N EUCLID	TUCSON	AZ	85722	742652689	IRC 115	$237,695	THERAPEUTICS DISCOVERY RESEARCH
ARIZONA BOARD OF REGENTS UNIVERSITY OF ARIZONA
888 N EUCLID	TUCSON	AZ	85722	742652689	IRC 115	$27,000	ADHERENCE
ARIZONA BOARD OF REGENTS UNIVERSITY OF ARIZONA
888 N EUCLID	TUCSON	AZ	85722	742652689	IRC 115	$181,186	CLINICAL RESEARCH CENTER
ARIZONA BOARD OF REGENTS UNIVERSITY OF ARIZONA
888 N EUCLID	TUCSON	AZ	85722	742652689	IRC 115	$228,778	CLINICAL RESEARCH STUDY
ATLANTIC HEALTH SYSTEM
100 MADISON AVENUE	MORRISTOWN	NJ	07962	521958352	501C(3)	$326,345	CLINICAL RESEARCH CENTER
BAYLOR COLLEGE OF MEDICINE
PO BOX 1	HOUSTON	TX	77212	741613878	501C(3)	$67,981	CLINICAL RESEARCH
BAYLOR COLLEGE OF MEDICINE
PO BOX 1	HOUSTON	TX	77212	741613878	501C(3)	$378,132	CLINICAL RESEARCH CENTER
BETH ISRAEL MEDICAL CENTER
160 WATER STREET	NEW YORK	NY	10038	135564934	501C(3)	$268,845	CLINICAL RESEARCH CENTER
BOARD OF REGENTS OF THE UNIVERSITY OF WISCONSIN SY
21 N PARK ST	MADISON	WI	537151218	396006492	IRC 115	$270,801	CLINICAL RESEARCH CENTER
BOARD OF REGENTS OF THE UNIVERSITY OF WISCONSIN SY
21 N PARK ST	MADISON	WI	537151218	396006492	IRC 115	$447,873	CLINICAL RESEARCH STUDY
BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UN
651 SERRA STREET	STANFORD	CA	943056215	941156365	501C(3)	$27,000	ADHERENCE
BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UN
651 SERRA STREET	STANFORD	CA	943056215	941156365	501C(3)	$312,836	CLINICAL RESEARCH CENTER
BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UN
651 SERRA STREET	STANFORD	CA	943056215	941156365	501C(3)	$216,000	THERAPEUTICS DISCOVERY RESEARCH
CASE WESTERN RESERVE UNIVERSITY
10900 EUCLID AVENUE	CLEVELAND	OH	441067015	341018992	501C(3)	$534,453	CLINICAL RESEARCH CENTER
CASE WESTERN RESERVE UNIVERSITY
10900 EUCLID AVENUE	CLEVELAND	OH	441067037	341018992	501C(3)	$1,273,475	THERAPEUTICS DISCOVERY RESEARCH
CEDARS-SINAI MEDICAL CENTER
8700 BEVERLY BOULEVARD	LOS ANGELES	CA	90048	951644600	501C(3)	$162,000	THERAPEUTICS DISCOVERY RESEARCH
CHILDREN'S HEALTH CARE
2525 CHICAGO AVENUE SOUTH	MINNEAPOLIS	MN	554041844	411754276	501C(3)	$6,316	CLINICAL RESEARCH
CHILDREN'S HEALTH CARE
2525 CHICAGO AVENUE SOUTH	MINNEAPOLIS	MN	554041844	411754276	501C(3)	$168,024	CLINICAL RESEARCH CENTER
CHILDREN'S HOSPITAL CORPORATION (BOSTON CHILDREN'S
300 LONGWOOD AVENUE	BOSTON	MA	02115	042774441	501C(3)	$45,821	ACADEMIC ADVISORY AWARD
CHILDREN'S HOSPITAL CORPORATION (BOSTON CHILDREN'S
300 LONGWOOD AVENUE	BOSTON	MA	02115	042774441	501C(3)	$392,973	ADHERENCE
CHILDREN'S HOSPITAL CORPORATION (BOSTON CHILDREN'S
300 LONGWOOD AVENUE	BOSTON	MA	02115	042774441	501C(3)	$314,179	CLINICAL RESEARCH CENTER
CHILDREN'S HOSPITAL CORPORATION (BOSTON CHILDREN'S
300 LONGWOOD AVENUE	BOSTON	MA	02115	042774441	501C(3)	$208,250	THERAPEUTICS DISCOVERY RESEARCH
CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUE	CINCINNATI	OH	45229	310833936	501C(3)	$22,913	ACADEMIC ADVISORY AWARD
CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUE	CINCINNATI	OH	45229	310833936	501C(3)	$27,000	ADHERENCE
CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUE	CINCINNATI	OH	45229	310833936	501C(3)	$108,731	CLINICAL RESEARCH
CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUE	CINCINNATI	OH	45229	310833936	501C(3)	$177,693	CLINICAL RESEARCH CENTER
CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUE	CINCINNATI	OH	45229	310833936	501C(3)	$1,077,843	CLINICAL RESEARCH STUDY
CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUE	CINCINNATI	OH	45229	310833936	501C(3)	$344,664	THERAPEUTICS DISCOVERY RESEARCH
CHILDREN'S HOSPITAL MEDICAL CENTER OF AKRON
1 PERKINS SQUARE	AKRON	OH	44308	340714357	501C(3)	$89,662	CLINICAL RESEARCH CENTER
CHILDREN'S HOSPITAL LOS ANGELES
4650 SUNSET BLVD	LOS ANGELES	CA	90027	951690977	501C(3)	$148,296	CLINICAL RESEARCH CENTER
CHILDREN'S MEDICAL CENTER
ONE CHILDRENS PLAZA	DAYTON	OH	45404	310672132	501C(3)	$158,148	CLINICAL RESEARCH CENTER
CONNECTICUT CHILDREN'S MEDICAL CENTER
282 WASHINGTON STREET	HARTFORD	CT	06106	060646755	501C(3)	$67,669	CLINICAL RESEARCH CENTER
COOK CHILDREN'S MEDICAL CENTER
801 SEVENTH AVENUE	FT WORTH	TX	76104	752051646	501C(3)	$270,377	CLINICAL RESEARCH CENTER
DANA-FARBER CANCER INSTITUTE
450 BROOKLINE AVENUE	BOSTON	MA	022155450	042263040	501C(3)	$162,000	THERAPEUTICS DISCOVERY RESEARCH
PHILADELPHIA HEALTH & EDUCATION CORPORATION
3201 ARCH STREET	PHILADELPHIA	PA	19104	232979433	501C(3)	$93,186	CLINICAL RESEARCH CENTER
EMORY UNIVERSITY
1784 N DECATUR ROAD	ATLANTA	GA	30322	580566256	501C(3)	$332,952	CLINICAL RESEARCH CENTER
EMORY UNIVERSITY
1784 N DECATUR ROAD	ATLANTA	GA	30322	580566256	501C(3)	$108,000	CLINICAL RESEARCH STUDY
EMORY UNIVERSITY
1784 N DECATUR ROAD	ATLANTA	GA	30322	580566256	501C(3)	$495,609	THERAPEUTICS DISCOVERY RESEARCH
GEORGIA HEALTH SCIENCES UNIVERSITY RESEARCH INSTIT
1120 15TH STREET	AUGUSTA	GA	309124810	581418202	501C(3)	$116,053	CLINICAL RESEARCH STUDY
GEORGIA INSTITUTE OF TECHNOLOGY
505 10TH STREET	ATLANTA	GA	30332	586002023	IRC 115	$264,611	THERAPEUTICS DISCOVERY RESEARCH
KAISER FOUNDATION RESEARCH INSTITUTE
1800 HARRISON STREET	OAKLAND	CA	94612	941105628	501C(3)	$159,548	CLINICAL RESEARCH CENTER
KAISER FOUNDATION RESEARCH INSTITUTE
1800 HARRISON STREET	OAKLAND	CA	94612	941105628	501C(3)	$57,979	CLINICAL RESEARCH STUDY
LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER
642 CSRB 533 BOLIVAR ST	NEW ORLEANS	LA	70112	726087770	115	$162,000	THERAPEUTICS DISCOVERY RESEARCH
MAINE MEDICAL CENTER
22 BRAMHALL STREET	PORTLAND	ME	041023175	010238552	501C(3)	$140,292	CLINICAL RESEARCH CENTER
MEDICAL UNIVERSITY OF SOUTH CAROLINA
PO BOX 997	CHARLESTON	SC	29402	576000722	115	$207,863	CLINICAL RESEARCH CENTER
MEDICAL UNIVERSITY OF SOUTH CAROLINA
PO BOX 997	CHARLESTON	SC	29402	576000722	115	$31,486	CLINICAL RESEARCH STUDY
MEMORIAL CHILDREN'S HOSPITAL
2801 ATLANTIC AVENUE	LONG BEACH	CA	90806	953527031	501C(3)	$300,657	CLINICAL RESEARCH CENTER
MEMORIAL SLOAN KETTERING CANCER CENTER
485 LEXINGTON AVENUE	NEW YORK	NY	10017	131924236	501C(3)	$54,097	CLINICAL RESEARCH STUDY
MONMOUTH MEDICAL CENTER FOUNDATION
300 SECOND AVENUE	LONG BRANCH	NJ	07740	222456079	501C(3)	$72,203	CLINICAL RESEARCH CENTER
NATIONAL JEWISH MEDICAL AND RESEARCH CENTER
1400 JACKSON STREET	DENVER	CO	80206	742044647	501C(3)	$27,000	ADHERENCE
NATIONAL JEWISH MEDICAL AND RESEARCH CENTER
1400 JACKSON STREET	DENVER	CO	80206	742044647	501C(3)	$187,775	CLINICAL RESEARCH CENTER
NATIONAL JEWISH MEDICAL AND RESEARCH CENTER
1400 JACKSON STREET	DENVER	CO	80206	742044647	501C(3)	$395,353	CLINICAL RESEARCH STUDY
NEMOURS CHILDREN'S CLINIC ORLANDO
10140 CENTURION PARKWAY NORTH	JACKSONVILLE	FL	32256	590634433	501C(3)	$127,526	CLINICAL RESEARCH CENTER
NORTHWESTERN UNIVERSITY
633 CLARK STREET	EVANSTON	IL	60208	362167817	501C(3)	$27,000	ADHERENCE
NORTHWESTERN UNIVERSITY
633 CLARK STREET	EVANSTON	IL	60208	362167817	501C(3)	$130,181	CLINICAL RESEARCH CENTER
OREGON HEALTH & SCIENCE UNIVERSITY
0690 SW BANCROFT STREET	PORTLAND	OR	97239	237083114	501C(3)	$24,984	CLINICAL RESEARCH
OREGON HEALTH & SCIENCE UNIVERSITY
0690 SW BANCROFT STREET	PORTLAND	OR	97239	237083114	501C(3)	$206,774	CLINICAL RESEARCH CENTER
OREGON HEALTH & SCIENCE UNIVERSITY
0690 SW BANCROFT STREET	PORTLAND	OR	97239	237083114	501C(3)	$507,192	THERAPEUTICS DISCOVERY RESEARCH
OSF SAINT FRANCIS MEDICAL CENTER
420 NE GLEN OAK AVENUE	PEORIA	IL	61603	370662569	501C(3)	$83,238	CLINICAL RESEARCH CENTER
PENNSYLVANIA STATE UNIVERSITY
OFFICE OF RESEARCH AFFAIRS	HERSHEY	PA	17033	246000376	115	$111,433	CLINICAL RESEARCH CENTER
PROVIDENCE ALASKA MEDICAL CENTER
4045 LAKE OTIS PKWY	ANCHORAGE	AK	99508	920016429	501C(3)	$70,040	CLINICAL RESEARCH CENTER
REGENTS OF THE UNIVERSITY OF COLORADO AT DENVER
ANSCHUTZ MEDICAL CAMPUS	AURORA	CO	80045	846000555	501C(3)	$346,088	THERAPEUTICS DISCOVERY RESEARCH
REGENTS OF THE UNIVERSITY OF COLORADO AT DENVER
ANSCHUTZ MEDICAL CAMPUS	AURORA	CO	80045	846000555	501C(3)	$23,441	ACADEMIC ADVISORY AWARD
REGENTS OF THE UNIVERSITY OF COLORADO AT DENVER
ANSCHUTZ MEDICAL CAMPUS	AURORA	CO	80045	846000555	501C(3)	$26,668	ADHERENCE
REGENTS OF THE UNIVERSITY OF COLORADO AT DENVER
ANSCHUTZ MEDICAL CAMPUS	AURORA	CO	80045	846000555	501C(3)	$568,442	CLINICAL RESEARCH
REGENTS OF THE UNIVERSITY OF COLORADO AT DENVER
ANSCHUTZ MEDICAL CAMPUS	AURORA	CO	80045	846000555	501C(3)	$288,972	CLINICAL RESEARCH CENTER
REGENTS OF THE UNIVERSITY OF COLORADO AT DENVER
ANSCHUTZ MEDICAL CAMPUS	AURORA	CO	80045	846000555	501C(3)	$316,720	CLINICAL RESEARCH STUDY
THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW
PO BOX 9	ALBANY	NY	122010009	141368361	501C(3)	$54,000	ADHERENCE
THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW
PO BOX 9	ALBANY	NY	122010009	141368361	501C(3)	$96,526	CLINICAL RESEARCH
THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW
PO BOX 9	ALBANY	NY	122010009	141368361	501C(3)	$415,644	CLINICAL RESEARCH CENTER
RUTGERS THE STATE UNIVERSITY OF NEW JERSEY
3 RUTGERS PLAZA	NEW BRUNSWICK	NJ	08901	462354111	IRC 115	$181,062	CLINICAL RESEARCH CENTER
SANFORD CHILDRENS SPECIALITY CLINIC
1600 W 22 STREET	SIOUX FALLS	SD	57105	460447693	501C(3)	$181,290	CLINICAL RESEARCH CENTER
SEATTLE CHILDREN'S HOSPITAL
4800 SAND POINT WAY NE	SEATTLE	WA	98105	910564748	501C(3)	$7,829,983	CLINICAL RESEARCH
SEATTLE CHILDREN'S HOSPITAL
4800 SAND POINT WAY NE	SEATTLE	WA	98105	910564748	501C(3)	$4,350,544	CLINICAL RESEARCH CENTER
SEATTLE CHILDREN'S HOSPITAL
4800 SAND POINT WAY NE	SEATTLE	WA	98105	910564748	501C(3)	$2,200,704	CLINICAL RESEARCH STUDY
SETON HEALTHCARE DELL CHILDREN'S
4900 MUELLER BLVD	AUSTIN	TX	78723	741109643	501C(3)	$163,609	CLINICAL RESEARCH CENTER
SPECTRUM HEALTH FOUNDATION
100 MICHIGAN STREET NE	GRAND RAPIDS	MI	49503	382752328	501C(3)	$156,618	CLINICAL RESEARCH CENTER
ST LOUIS UNIVERSITY
3500 LINDELL BLVD	ST LOUIS	MO	63103	430654872	501C(3)	$168,935	CLINICAL RESEARCH CENTER
ST LUKE'S REGIONAL MEDICAL CENTER
100 EAST IDAHO	BOISE	ID	83712	820161600	501C(3)	$101,594	CLINICAL RESEARCH CENTER
TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER
3601 4TH STREET	LUBBOCK	TX	79430	752668014	IRC 115	$164,866	THERAPEUTICS DISCOVERY RESEARCH
THE CHILDREN'S HOSPITAL OF PHILADELPHIA
34TH AND CIVIC CENTER BOULEVARD	PHILADELPHIA	PA	19104	231352166	501C(3)	$49,105	CLINICAL RESEARCH
THE CHILDREN'S HOSPITAL OF PHILADELPHIA
34TH AND CIVIC CENTER BOULEVARD	PHILADELPHIA	PA	19104	231352166	501C(3)	$224,658	CLINICAL RESEARCH CENTER
THE CHILDREN'S MERCY HOSPITAL
2401 GILLHAM ROAD	KANSAS CITY	MO	61408	440605373	501C(3)	$64,749	CLINICAL RESEARCH
THE CHILDREN'S MERCY HOSPITAL
2401 GILLHAM ROAD	KANSAS CITY	MO	61408	440605373	501C(3)	$194,878	CLINICAL RESEARCH CENTER
THE CURATORS OF THE UNIVERSITY OF MISSOURI
310 JESSE HALL	COLUMBIA	MO	65211	436003859	IRC 115	$22,156	THERAPEUTICS DISCOVERY RESEARCH
THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
350 COMMUNITY DRIVE	MANHASSET	NY	11030	112673595	501C(3)	$173,140	CLINICAL RESEARCH CENTER
THE GENERAL HOSPITAL CORPORATION (MASSACHUSETTS GE
PO BOX 414876	BOSTON	MA	022414876	042697983	501C(3)	$174,707	CLINICAL RESEARCH CENTER
THE GENERAL HOSPITAL CORPORATION (MASSACHUSETTS GE
PO BOX 414876	BOSTON	MA	022414876	042697983	501C(3)	$211,741	THERAPEUTICS DISCOVERY RESEARCH
THE HITCHCOCK FOUNDATION
ONE MEDICAL CENTER DRIVE	LEBANON	NH	03756	020222139	501C(3)	$225,985	CLINICAL RESEARCH CENTER
THE HITCHCOCK FOUNDATION
ONE MEDICAL CENTER DRIVE	LEBANON	NH	03756	020222139	501C(3)	$106,375	CLINICAL RESEARCH STUDY
THE JOHNS HOPKINS UNIVERSITY
600 N WOLFE STREET	BALTIMORE	MD	21205	520595110	501C(3)	$288,562	ADHERENCE
THE JOHNS HOPKINS UNIVERSITY
600 N WOLFE STREET	BALTIMORE	MD	21205	520595110	501C(3)	$397,969	CLINICAL RESEARCH CENTER
THE JOHNS HOPKINS UNIVERSITY
600 N WOLFE STREET	BALTIMORE	MD	21205	520595110	501C(3)	$1,165,166	CLINICAL RESEARCH STUDY
THE JOHNS HOPKINS UNIVERSITY
600 N WOLFE STREET	BALTIMORE	MD	21205	520595110	501C(3)	$897,363	THERAPEUTICS DISCOVERY RESEARCH
THE MEDICAL COLLEGE OF WISCONSIN
8701 WATERTOWN PLK RD	MILWAUKEE	WI	53226	390806261	501C(3)	$232,145	CLINICAL RESEARCH CENTER
THE RECTOR AND VISITORS OF THE UNIVERSITY OF VIRGI
PO BOX 400195	CHARLOTTESVILLE	VA	229044195	546001796	501C(3)	$166,460	CLINICAL RESEARCH CENTER
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN D
9500 GILMAN DRIVE	LA JOLLA	CA	920930984	956006144	501C(3)	$187,490	CLINICAL RESEARCH CENTER
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN D
9500 GILMAN DRIVE	LA JOLLA	CA	920930984	956006144	501C(3)	$144,000	THERAPEUTICS DISCOVERY RESEARCH
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN F
3333 CALIFORNIA STREET	SAN FRANCISCO	CA	941430962	956006144	501C(3)	$161,200	THERAPEUTICS DISCOVERY RESEARCH
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
3003 SOUTH STATE STREET	ANN ARBOR	MI	481091274	386006309	501C(3)	$26,214	ADHERENCE
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
3003 SOUTH STATE STREET	ANN ARBOR	MI	481091274	386006309	501C(3)	$214,351	CLINICAL RESEARCH CENTER
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
3003 SOUTH STATE STREET	ANN ARBOR	MI	481091274	386006309	501C(3)	$566,002	CLINICAL RESEARCH STUDY
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
3003 SOUTH STATE STREET	ANN ARBOR	MI	481091274	386006309	501C(3)	$81,000	THERAPEUTICS DISCOVERY RESEARCH
THE REGENTS OF THE UNIVERSITY OF MINNESOTA
200 OAK STREET SE	MINNEAPOLIS	MN	554552070	416007513	IRC 115	$45,988	ACADEMIC ADVISORY AWARD
THE REGENTS OF THE UNIVERSITY OF MINNESOTA
200 OAK STREET SE	MINNEAPOLIS	MN	554552070	416007513	IRC 115	$86,967	CLINICAL RESEARCH
THE REGENTS OF THE UNIVERSITY OF MINNESOTA
200 OAK STREET SE	MINNEAPOLIS	MN	554552070	416007513	IRC 115	$297,470	CLINICAL RESEARCH CENTER
THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HO
700 CHILDRENS DRIVE	COLUMBUS	OH	43205	316056230	501C(3)	$332,655	CLINICAL RESEARCH CENTER
THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HO
700 CHILDRENS DRIVE	COLUMBUS	OH	43205	316056230	501C(3)	$199,594	THERAPEUTICS DISCOVERY RESEARCH
THE SCRIPPS RESEARCH INSTITUTE
10666 NORTH TORREY PINES ROAD	LA JOLLA	CA	92037	330435954	501C(3)	$193,350	THERAPEUTICS DISCOVERY RESEARCH
THE TOLEDO HOSPITAL
2142 N COVE BLVD	TOLEDO	OH	43606	344428256	501C(3)	$126,510	CLINICAL RESEARCH CENTER
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF
PO BOX 29789	NEW YORK	NY	100879789	135598093	501C(3)	$391,865	CLINICAL RESEARCH CENTER
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF
PO BOX 29789	NEW YORK	NY	100879789	135598093	501C(3)	$223,619	CLINICAL RESEARCH STUDY
THE UNIVERSITY OF ALABAMA AT BIRMINGHAM
1530 3RD AVE S	BIRMINGHAM	AL	352940006	636005396	501C(3)	$56,760	ACADEMIC ADVISORY AWARD
THE UNIVERSITY OF ALABAMA AT BIRMINGHAM
1530 3RD AVE S	BIRMINGHAM	AL	352940006	636005396	501C(3)	$27,000	ADHERENCE
THE UNIVERSITY OF ALABAMA AT BIRMINGHAM
1530 3RD AVE S	BIRMINGHAM	AL	352940006	636005396	501C(3)	$218,156	CLINICAL RESEARCH
THE UNIVERSITY OF ALABAMA AT BIRMINGHAM
1530 3RD AVE S	BIRMINGHAM	AL	352940006	636005396	501C(3)	$366,078	CLINICAL RESEARCH CENTER
THE UNIVERSITY OF ALABAMA AT BIRMINGHAM
1530 3RD AVE S	BIRMINGHAM	AL	352940006	636005396	501C(3)	$1,208,857	THERAPEUTICS DISCOVERY RESEARCH
THE UNIVERSITY OF CHICAGO
970 E 58TH STREET	CHICAGO	IL	60637	362177139	501C(3)	$26,061	ACADEMIC ADVISORY AWARD
THE UNIVERSITY OF IOWA
OFFICE OF VP FOR RESEARCH	IOWA CITY	IA	52242	426004813	IRC 115	$218,397	CLINICAL RESEARCH CENTER
THE UNIVERSITY OF IOWA
OFFICE OF VP FOR RESEARCH	IOWA CITY	IA	52242	426004813	IRC 115	$2,239,943	THERAPEUTICS DISCOVERY RESEARCH
THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
300 BYNUM HALL	CHAPEL HILL	NC	275994100	566001393	501C(3)	$24,181	ACADEMIC ADVISORY AWARD
THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
300 BYNUM HALL	CHAPEL HILL	NC	275994100	566001393	501C(3)	$83,221	CLINICAL RESEARCH
THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
300 BYNUM HALL	CHAPEL HILL	NC	275994100	566001393	501C(3)	$435,446	CLINICAL RESEARCH CENTER
THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
300 BYNUM HALL	CHAPEL HILL	NC	275994100	566001393	501C(3)	$276,707	CLINICAL RESEARCH STUDY
THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
300 BYNUM HALL	CHAPEL HILL	NC	275994100	566001393	501C(3)	$1,243,723	THERAPEUTICS DISCOVERY RESEARCH
THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT H
PO BOX 203382	HOUSTON	TX	77216	741761309	IRC 115	$380,000	THERAPEUTICS DISCOVERY RESEARCH
THE UNIVERSITY OF UTAH
201 S PRESIDENTS CIRCLE	SALT LAKE CITY	UT	84112	876000525	501C(3)	$301,289	CLINICAL RESEARCH CENTER
THE UNIVERSITY OF UTAH
201 S PRESIDENTS CIRCLE	SALT LAKE CITY	UT	84112	876000525	501C(3)	$465,237	CLINICAL RESEARCH STUDY
THE UNIVERSITY OF VERMONT AND STATE AGRICULTURAL C
223 WATERMAN BLDG	BURLINGTON	VT	05405	030179440	501C(3)	$147,424	CLINICAL RESEARCH CENTER
THE UNIVERSITY OF VERMONT AND STATE AGRICULTURAL C
223 WATERMAN BLDG	BURLINGTON	VT	05405	030179440	501C(3)	$150,000	THERAPEUTICS DISCOVERY RESEARCH
TRUSTEES OF BOSTON UNIVERSITY
25 BUICK STREET	BOSTON	MA	02215	042103547	501C(3)	$81,000	THERAPEUTICS DISCOVERY RESEARCH
TRUSTEES OF INDIANA UNIVERSITY
PO BOX 66057	INDIANAPOLIS	IN	462666057	356001673	501C(3)	$382,742	CLINICAL RESEARCH CENTER
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
133 SOUTH 36TH STREET	PHILADELPHIA	PA	191043246	231352685	501C(3)	$55,102	CLINICAL RESEARCH CENTER
UNIVERSITY AT BUFFALO PEDIATRIC ASSOCIATES
239 BRYANT STREET	BUFFALO	NY	14222	161238821	501C(3)	$12,636	CLINICAL RESEARCH
UNIVERSITY OF ALABAMA IN HUNTSVILLE
301 SPARKMAN DRIVE SW	HUNSTVILLE	AL	35899	630520830	501C(3)	$145,126	THERAPEUTICS DISCOVERY RESEARCH
UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES
4301 WEST MARKHAM STREET	LITTLE ROCK	AR	72205	716046242	IRC 115	$98,960	CLINICAL RESEARCH CENTER
UNIVERSITY OF CINCINNATI PHYSICIANS COMPANY
231 ALBERT SABIN WAY	CINCINNATI	OH	45267	311435820	501C(3)	$153,539	CLINICAL RESEARCH CENTER
UNIVERSITY OF COLORADO HEALTH SCIENCES CENTER
4200 E 9TH AVENUE	DENVER	CO	80262	846000555	501C(3)	$856,012	CLINICAL RESEARCH STUDY
UNIVERSITY OF FLORIDA
123 GRINTER HALL	GAINESVILLE	FL	32611	596002052	IRC 115	$135,845	CLINICAL RESEARCH CENTER
UNIVERSITY OF FLORIDA
123 GRINTER HALL	GAINESVILLE	FL	32611	596002052	IRC 115	$108,000	THERAPEUTICS DISCOVERY RESEARCH
UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
55 LAKE AVENUE NORTH	WORCESTER	MA	01655	043167352	IRC 115	$182,322	CLINICAL RESEARCH CENTER
UNIVERSITY OF MIAMI
PO BOX 025405	MIAMI	FL	331025405	590624458	501C(3)	$27,000	ADHERENCE
UNIVERSITY OF MIAMI
PO BOX 025405	MIAMI	FL	331025405	590624458	501C(3)	$189,505	CLINICAL RESEARCH CENTER
UNIVERSITY OF NEBRASKA MEDICAL CENTER
985100 NEBRASKA MEDICAL CENTER	OMAHA	NE	681985190	470491233	501C(3)	$210,962	CLINICAL RESEARCH CENTER
UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER
PO BOX 26901	OKLAHOMA CITY	OK	73190	736017987	IRC 115	$173,593	CLINICAL RESEARCH CENTER
UNIVERSITY OF PITTSBURGH
PO BOX 371220	PITTSBURGH	PA	15251	250965591	501C(3)	$108,000	THERAPEUTICS DISCOVERY RESEARCH
UNIVERSITY OF PITTSBURGH
PO BOX 371220	PITTSBURGH	PA	15251	250965591	501C(3)	$198,686	CLINICAL RESEARCH
UNIVERSITY OF PITTSBURGH
PO BOX 371220	PITTSBURGH	PA	15251	250965591	501C(3)	$371,309	CLINICAL RESEARCH CENTER
UNIVERSITY OF PITTSBURGH
PO BOX 371220	PITTSBURGH	PA	15251	250965591	501C(3)	$208,000	CLINICAL RESEARCH STUDY
UNIVERSITY OF PITTSBURGH
PO BOX 371220	PITTSBURGH	PA	15251	250965591	501C(3)	$470,505	THERAPEUTICS DISCOVERY RESEARCH
UNIVERSITY OF ROCHESTER
601 ELMWOOD AVENUE	ROCHESTER	NY	14642	160743209	501C(3)	$38,918	CLINICAL RESEARCH
UNIVERSITY OF ROCHESTER
601 ELMWOOD AVENUE	ROCHESTER	NY	14642	160743209	501C(3)	$158,787	CLINICAL RESEARCH CENTER
UNIVERSITY OF ROCHESTER
601 ELMWOOD AVENUE	ROCHESTER	NY	14642	160743209	501C(3)	$81,000	THERAPEUTICS DISCOVERY RESEARCH
UNIVERSITY OF SOUTHERN CALIFORNIA
1540 ALCAZAR STREET	LOS ANGELES	CA	90033	951642394	501C(3)	$153,247	CLINICAL RESEARCH CENTER
UNIVERSITY OF SOUTHERN CALIFORNIA
1540 ALCAZAR STREET	LOS ANGELES	CA	90033	951642394	501C(3)	$298,464	THERAPEUTICS DISCOVERY RESEARCH
UNIVERSITY OF TENNESSEE
62 S DUNLAP	MEMPHIS	TN	38163	626001636	IRC 115	$78,027	CLINICAL RESEARCH CENTER
UNIVERSITY OF WASHINGTON
4333 BROOKLYN AVENUE NE	SEATTLE	WA	981056692	916001537	IRC 115	$243,000	THERAPEUTICS DISCOVERY RESEARCH
UNIVERSITY OF WASHINGTON
4333 BROOKLYN AVENUE NE	SEATTLE	WA	981056692	916001537	IRC 115	$181,162	CLINICAL RESEARCH CENTER
UNIVERSITY OF WASHINGTON
4333 BROOKLYN AVENUE NE	SEATTLE	WA	981056692	916001537	IRC 115	$100,000	CLINICAL RESEARCH STUDY
UNIVERSITY OF WASHINGTON
4333 BROOKLYN AVENUE NE	SEATTLE	WA	981056692	916001537	IRC 115	$30,330	THERAPEUTICS DISCOVERY RESEARCH
UT SOUTHWESTERN MEDICAL CENTER AT DALLAS
5323 HARRY HINES BOULEVARD	DALLAS	TX	753909105	756002868	IRC 115	$325,724	CLINICAL RESEARCH CENTER
UT SOUTHWESTERN MEDICAL CENTER AT DALLAS
5323 HARRY HINES BOULEVARD	DALLAS	TX	753909105	756002868	IRC 115	$130,000	CLINICAL RESEARCH STUDY
UT SOUTHWESTERN MEDICAL CENTER AT DALLAS
5323 HARRY HINES BOULEVARD	DALLAS	TX	753909105	756002868	IRC 115	$465,736	THERAPEUTICS DISCOVERY RESEARCH
VANDERBILT UNIVERSITY
PO BOX 30195	NASHVILLE	TN	372410195	620476822	501C(3)	$109,021	CLINICAL RESEARCH CENTER
VIA CHRISTI REGIONAL MEDICAL CENTER INC
707 N EMPORIA	WICHITA	KS	67214	481172106	501C(3)	$65,991	CLINICAL RESEARCH CENTER
VIRGINIA COMMONWEALTH UNIVERSITY
BOX 2506	RICHMOND	VA	232842506	546001758	IRC 115	$27,000	ADHERENCE
VIRGINIA COMMONWEALTH UNIVERSITY
BOX 2506	RICHMOND	VA	232842506	546001758	IRC 115	$77,080	CLINICAL RESEARCH CENTER
VIRGINIA COMMONWEALTH UNIVERSITY
BOX 2506	RICHMOND	VA	232842506	546001758	IRC 115	$259,477	CLINICAL RESEARCH STUDY
WAKE FOREST UNIVERSITY HEALTH SCIENCES
MEDICAL CENTER BLVD	WINSTONSALEM	NC	271571064	223849199	501C(3)	$61,280	CLINICAL RESEARCH CENTER
WASHINGTON UNIVERSITY
660 S EUCLID AVENUE	ST LOUIS	MO	63110	430653611	501C(3)	$354,752	CLINICAL RESEARCH CENTER
WAYNE STATE UNIVERSITY
RESEARCH AND SPONSORED PROGRAMS	DETROIT	MI	48201	383028425	501C(3)	$185,704	CLINICAL RESEARCH CENTER
WAYNE STATE UNIVERSITY
RESEARCH AND SPONSORED PROGRAMS	DETROIT	MI	48201	383028425	501C(3)	$150,000	THERAPEUTICS DISCOVERY RESEARCH
WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY
1300 YORK AVENUE	NEW YORK	NY	10021	150532082	501C(3)	$162,000	THERAPEUTICS DISCOVERY RESEARCH
YALE UNIVERSITY
47 COLLEGE STREET	NEW HAVEN	CT	065208047	060646973	501C(3)	$67,977	CLINICAL RESEARCH CENTER
YALE UNIVERSITY
47 COLLEGE STREET	NEW HAVEN	CT	065208047	060646973	501C(3)	$108,000	CLINICAL RESEARCH STUDY
YALE UNIVERSITY
47 COLLEGE STREET	NEW HAVEN	CT	065208047	060646973	501C(3)	$165,845	THERAPEUTICS DISCOVERY RESEARCH

Field	Value	IRS element (for citing)
Total501c3 Org	97	Total501c3OrgCnt

Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp

Field	Value	IRS element (for citing)
Grant Type	FELLOWSHIP	GrantTypeTxt
Recipient	1	RecipientCnt
Cash Grant	$7,000	CashGrantAmt

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PROCEDURES FOR MONITORING GRANT FUNDS INSIDE OF THE U.S.	FormAndLineReferenceDesc
Explanation	PART I, LINE 2 THE ORGANIZATION HAS PROCEDURES IN PLACE TO MONITOR THE SCIENTIFIC PROGRESS AND FINANCIAL ASPECTS OF GRANT FUNDS AWARDED TO ENTITIES INSIDE OF THE U.S. SPONSORED INSTITUTIONS ARE REQUIRED TO SUBMIT ANNUAL REPORTS OF EXPENDITURES AS WELL AS SCIENTIFIC PROGRESS REPORTS. SCIENTIFIC REPORTS ARE REVIEWED BY THE ORGANIZATION'S SCIENTIFIC STAFF TO ENSURE PROGRESS HAS BEEN ATTAINED. THE FINAL GRANT PAYMENT IS CONTINGENT UPON RECEIPT AND APPROVAL OF THE REPORT OF EXPENDITURES. REPORTS OF EXPENDITURES ARE REVIEWED AND APPROVED BY STAFF TO ENSURE INCURRED COSTS ARE APPROPRIATE. THE CF FOUNDATION'S INTERNAL AUDITORS CONDUCT AUDITS ON SAMPLES OF GRANT EXPENDITURE REPORTS BY EXAMINING SUPPORTING RECORDS FROM THE SPONSORED INSTITUTION. SCHEDULE I, PART III FELLOWSHIPS ARE AWARDED TO INVESTIGATORS CONDUCTING RESEARCH RELATED TO GRANTS REPORTED IN PART II. SEE SUPPLEMENTAL INFORMATION FOR PART I, LINE 2 FOR PROCEDURES USED TO MONITOR THESE GRANTS. PRIOR TO MAKING FELLOWSHIP PAYMENTS, SUPPORTING DOCUMENTATION OF EXPENDITURES ARE REVIEWED AND APPROVED BY STAFF TO ENSURE INCURRED COSTS ARE APPROPRIATE.	ExplanationTxt

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
Compensation Committee	Yes (X)	CompensationCommitteeInd
Independent Consultant	Yes (X)	IndependentConsultantInd
Form990 Of Other Organizations	Yes (X)	Form990OfOtherOrganizationsInd
Written Employment Contract	Yes (X)	WrittenEmploymentContractInd
Compensation Survey	Yes (X)	CompensationSurveyInd
Board Or Committee Approval	Yes (X)	BoardOrCommitteeApprovalInd
Severance Payment	Yes (true)	SeverancePaymentInd
Supplemental Nonqual Rtr Plan	Yes (true)	SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm	false	EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org	false	CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs	false	CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org	false	CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs	false	CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments	Yes (true)	AnyNonFixedPaymentsInd
Initial Contract Exception	false	InitialContractExceptionInd
Rebuttable Presumption Proc	false	RebuttablePresumptionProcInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (9 entries)

TitleTitleTxt	Base Compensation Filing OrgBaseCompensationFilingOrgAmt	Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt	Bonus Filing OrganizationBonusFilingOrganizationAmount	Bonus Related OrganizationsBonusRelatedOrganizationsAmt	Other Compensation Filing OrgOtherCompensationFilingOrgAmt	Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt	Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt	Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt	Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt	Total Compensation Filing OrgTotalCompensationFilingOrgAmt	Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt	Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
PRESTON CAMPBELL MD
PRESIDENT & CEO (AS OF 10/1)	$144,690	$284,125	$93,316	$189,461	$7,565	$23,384	$51,623	$131,869	$0	$29,049	$297,194	$657,888	$30,544	$62,015
ROBERT BEALL PHD
PRESIDENT & CEO (UNTIL 9/30)	$206,690	$412,228	$135,956	$276,031	$436,584	$886,949	$20,043	$67,754	$0	$21,099	$799,273	$1,664,061	$106,173	$215,564
C RICHARD MATTINGLY
EXECUTIVE VP & COO	$0	$316,273	$0	$273,763	$0	$2,128,337	$0	$61,263	$0	$7,283	$0	$2,786,919	$0	$682,855
VERA H TWIGG
EXECUTIVE VP, CFO & SECRETARY	$0	$309,865	$0	$167,491	$0	$22,316	$0	$78,919	$0	$29,049	$0	$607,640	$0	$39,236
BRUCE MARSHALL MD
SENIOR VP OF CLINICAL AFFAIRS	$233,509	$116,754	$77,062	$13,000	$3,564	$0	$32,060	$0	$0	$0	$346,195	$129,754	$0	$0
MICHAEL P BOYLE MD
SENIOR VP OF THERAPEUTICS DEV.	$238,947	$0	$28,500	$0	$908	$0	$0	$0	$14,595	$0	$282,950	$0	$0	$0
CHRIS PENLAND PHD
VICE PRESIDENT OF RESEARCH	$110,144	$110,144	$12,284	$28,664	$0	$704	$0	$27,060	$0	$26,245	$122,428	$192,817	$0	$0
WILLIAM SKACH MD
SENIOR VP OF RESEARCH AFFAIRS	$200,449	$66,816	$29,498	$8,071	$3,557	$0	$20,704	$0	$27,789	$0	$281,997	$74,887	$0	$0
DAVID MCLOUGHLIN
SR. VP OF OPERATIONS	$86,994	$202,987	$21,107	$49,249	$0	$1,242	$0	$32,060	$0	$28,289	$108,101	$313,827	$0	$0

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
PART I, LINE 4A - SEVERANCE PAYMENT	MR. MATTINGLY RECEIVED SEVERANCE PAY FROM CYSTIC FIBROSIS FOUNDATION HEADQUARTERS ("CFF"), A RELATED ORGANIZATION, UPON HIS RETIREMENT AS EXECUTIVE VICE PRESIDENT AND COO OF CFF. HE HAD EXTRAORDINARY SUCCESSES ACHIEVED OVER HIS 37-YEAR TENURE. THE SEVERANCE WAS REVIEWED AND OPINED ON AS REASONABLE FROM A COMPETITIVE MARKET PERSPECTIVE BY THE CFF BOARDS INDEPENDENT COMPENSATION CONSULTANTS AND REVIEWED IN DETAIL AND APPROVED (IN THE MANNER SPECIFIED IN IRS REGULATIONS) BY THE CFF BOARD'S INDEPENDENT COMPENSATION COMMITTEE. ADDITIONAL INFORMATION, INCLUDING THE DOLLAR AMOUNT OF THE AWARD, IS PROVIDED IN THE ADDITIONAL INFORMATION FOR SCHEDULE J, PART II, BELOW.
PART I, LINE 4B - SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN	CERTAIN PERSONS LISTED IN FORM 990, PART VII, SECTION A PARTICIPATE IN A NONQUALIFIED DEFERRED COMPENSATION PLAN SPONSORED BY CYSTIC FIBROSIS FOUNDATION HEADQUARTERS ("CFF"), A RELATED ORGANIZATION. THE EXECUTIVES PARTICIPATE BY VIRTUE OF BEING AN OFFICER OF CFF. HOWEVER, BOTH CFFT AND CFF MAKE CONTRIBUTIONS ON THE EXECUTIVES BEHALF IF THE EXECUTIVE RECEIVES COMPENSATION FROM CFFT (AS AN OFFICER OF CFFT) AND FROM CFF (AS AN OFFICER OF CFF). NONQUALIFIED DEFERRED COMPENSATION PLAN INTERESTS ARE FORFEITED BY THE PARTICIPANT IF THE PARTICIPANT VOLUNTARILY TERMINATES EMPLOYMENT PRIOR TO THE DESIGNATED VESTING DATE. FURTHER INFORMATION ABOUT THE NONQUALIFIED DEFERRED COMPENSATION PLAN IN WHICH THOSE PERSONS PARTICIPATE, INCLUDING THE AMOUNT OF ANY PAYMENT MADE BY THE PLAN DURING THE REPORTING YEAR, IS PROVIDED IN THE ADDITIONAL INFORMATION FOR SCHEDULE J, PART II, BELOW. PART I, LINE 7: SEVERAL INDIVIDUALS LISTED IN FORM 990, PART VII, SECTION A, LINE 1A, (WHO ARE IDENTIFIED IN PART II, BELOW) PARTICIPATED IN AN INCENTIVE COMPENSATION PLAN, FROM WHICH NON-FIXED PAYMENTS NOT DESCRIBED IN LINES 5 AND 6 WERE PAID. THE PLAN IS SPONSORED BY CFF, A RELATED ORGANIZATION. THE INDIVIDUALS PARTICIPATE BY VIRTUE OF BEING OFFICERS OF CFF. HOWEVER, IF AN INDIVIDUAL ALSO IS AN OFFICER OF CFFT AND RECEIVES COMPENSATION FROM CFFT, A PORTION OF THE INDIVIDUALS AWARD IS PAID BY CFFT. THE INCENTIVE COMPENSATION PLAN PAYS NON-FIXED PAYMENTS SUBJECT TO, AND BASED ON, THE ACHIEVEMENT OF ANNUAL PERFORMANCE OBJECTIVES ESTABLISHED IN ADVANCE BY THE COMPENSATION COMMITTEE. IN ADDITION, THE INCENTIVE COMPENSATION PLAN PAYS NON-FIXED PAYMENTS THAT RELATE TO A THREE-YEAR PERFORMANCE PERIOD, SUBJECT TO, AND BASED ON, THE ACHIEVEMENT OF LONG-TERM PERFORMANCE OBJECTIVES ESTABLISHED IN ADVANCE BY THE COMPENSATION COMMITTEE. ANY FINANCIAL PERFORMANCE OBJECTIVES ESTABLISHED UNDER THE INCENTIVE COMPENSATION PLAN DO NOT INCLUDE PROGRAM-RELATED REVENUES (SUCH AS ROYALTY STREAMS, LUMP-SUM PAYMENTS, OTHER PROGRAM-RELATED INCOME, AND SALES PROCEEDS FROM TRANSFER OF THE FOREGOING TO THIRD PARTIES) RELATED TO THE DEVELOPMENT AND APPROVAL OF CF DRUGS. PART II: CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. EIN 91-2059167. (A) NAME: P. CAMPBELL, M.D.; (B)(I) BASE COMPENSATION: BASE SALARY - $144,690; (B)(II) BONUS & INCENTIVE COMPENSATION: ANNUAL INCENTIVE PLAN BENEFIT (1) $29,772, LONG-TERM INCENTIVE PLAN PAYMENT, WHICH WAS PREVIOUSLY REPORTED (6) - $30,544, LONG-TERM INCENTIVE PLAN TREATMENT AWARD (3) - $33,000; (B)(III) OTHER REPORTABLE COMPENSATION: OTHER BENEFITS - $1,625; SECTION 457(B) PLAN (5) - $5,940; (C) DEFERRED COMPENSATION: LONG-TERM INCENTIVE PLAN BENEFIT (6) - $31,040, SERP (4) - $20,583; (D) NONTAXABLE BENEFITS: $0; (F) COMPENSATION REPORTED IN PRIOR FORM 990 (9) - $30,544. CYSTIC FIBROSIS FOUNDATION - HEADQUARTERS. EIN 13-1930701. (A) NAME: P. CAMPBELL, M.D.; (B)(I) BASE COMPENSATION: BASE SALARY - $284,125; (B)(II) BONUS & INCENTIVE COMPENSATION: ANNUAL INCENTIVE PLAN BENEFIT (1) $60,446, LONG-TERM INCENTIVE PLAN PAYMENT, WHICH WAS PREVIOUSLY REPORTED (6) - $62,015, LONG-TERM INCENTIVE PLAN TREATMENT AWARD (3) - $67,000; (B)(III) OTHER REPORTABLE COMPENSATION: OTHER BENEFITS INCLUDING TAXABLE GENERAL ORGANIZATION GROUP TERM LIFE INSURANCE PREMIUM - $11,324, SECTION 457(B) PLAN (5) - $12,060; (C) DEFERRED COMPENSATION: RETIREMENT BENEFIT (2) $27,060, LONG-TERM INCENTIVE PLAN BENEFIT (6) - $63,020, SERP (4) - $41,789; (D) NONTAXABLE BENEFITS: EMPLOYER CONTRIBUTION TO GENERAL ORGANIZATION HEALTH PLAN BENEFIT - $19,409, EMPLOYEE CONTRIBUTION TO FLEXIBLE SPENDING ACCOUNT BENEFIT - $2,550, EMPLOYEE CONTRIBUTION TO GENERAL ORGANIZATION HEALTH PLAN BENEFIT - $7,090; (F) COMPENSATION REPORTED IN PRIOR FORM 990 (9) - $62,015. CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. EIN 91-2059167. (A) NAME: R. BEALL, PH.D.; (B)(I) BASE COMPENSATION: BASE SALARY - $198,770, 401(K) BONUS $7,920; (B)(II) BONUS & INCENTIVE COMPENSATION: ANNUAL INCENTIVE PLAN BENEFIT (1) $48,263, LONG-TERM INCENTIVE PLAN PAYMENT, WHICH WAS PREVIOUSLY REPORTED (6) - $41,493, LONG-TERM INCENTIVE PLAN TREATMENT AWARD (3) - $46,200; (B)(III) OTHER REPORTABLE COMPENSATION: HEALTH INSURANCE BENEFIT - $1,606, AUTOMOBILE ALLOWANCE - $2,376, OTHER BENEFITS - $4,125, ADDITIONAL AWARD (7) - $330,000; VESTED SERP ACCOUNT (8) - $98,477; (C) DEFERRED COMPENSATION: LONG-TERM INCENTIVE PLAN BENEFIT (6) - $20,043; (D) NONTAXABLE BENEFITS: $0; (F) COMPENSATION REPORTED IN PRIOR FORM 990 (9) - $106,173; CYSTIC FIBROSIS FOUNDATION - HEADQUARTERS. EIN 13-1930701. (A) NAME: R. BEALL, PH.D.; (B)(I) BASE COMPENSATION: BASE SALARY - $396,148, 401(K) BONUS $16,080; (B)(II) BONUS & INCENTIVE COMPENSATION: ANNUAL INCENTIVE PLAN BENEFIT (1) $97,988, LONG-TERM INCENTIVE PLAN PAYMENT, WHICH WAS PREVIOUSLY REPORTED (6) - $84,244, LONG-TERM INCENTIVE PLAN TREATMENT AWARD (3) - $93,800; (B)(III) OTHER REPORTABLE COMPENSATION: HEALTH INSURANCE BENEFIT - $3,260, AUTOMOBILE ALLOWANCE - $4,824, OTHER BENEFITS - $8,925, ADDITIONAL AWARD (7) - $670,000, VESTED SERP ACCOUNT (8) $199,939; (C) DEFERRED COMPENSATION: RETIREMENT BENEFIT (2) $27,060, LONG-TERM INCENTIVE PLAN BENEFIT (6) - $40,694 ; (D) NONTAXABLE BENEFITS: EMPLOYER CONTRIBUTION TO GENERAL ORGANIZATION HEALTH PLAN BENEFIT - $13,683, EMPLOYEE CONTRIBUTION TO FLEXIBLE SPENDING ACCOUNT BENEFIT - $2,550, EMPLOYEE CONTRIBUTION TO GENERAL ORGANIZATION HEALTH PLAN BENEFIT - $4,866; (F) COMPENSATION REPORTED IN PRIOR FORM 990 (9) - $215,564. CYSTIC FIBROSIS FOUNDATION - HEADQUARTERS. EIN 13-1930701. (A) NAME: R. MATTINGLY; (B)(I) BASE COMPENSATION: BASE SALARY - $316,273; (B)(II) BONUS & INCENTIVE COMPENSATION: ANNUAL INCENTIVE PLAN BENEFIT (1) $80,081, LONG-TERM INCENTIVE PLAN PAYMENT, WHICH WAS PREVIOUSLY REPORTED (6) - $93,682, LONG-TERM INCENTIVE PLAN TREATMENT AWARD (3) - $100,000; (B)(III) OTHER REPORTABLE COMPENSATION: SECTION 457(B) PLAN (5) - $18,000; OTHER BENEFITS INCLUDING TAXABLE GENERAL ORGANIZATION GROUP TERM LIFE INSURANCE PREMIUM - $4,384; SEVERANCE AWARD (10) - $1,142,587, VESTED SERP ACCOUNT (11) $963,366; (C) DEFERRED COMPENSATION: RETIREMENT BENEFIT (2) $27,060, LONG-TERM INCENTIVE PLAN BENEFIT (6) - $34,203; (D) NONTAXABLE BENEFITS: EMPLOYER CONTRIBUTION TO GENERAL ORGANIZATION HEALTH PLAN BENEFIT - $5,650, EMPLOYEE CONTRIBUTION TO FLEXIBLE SPENDING ACCOUNT BENEFIT - $658, EMPLOYEE CONTRIBUTION TO GENERAL ORGANIZATION HEALTH PLAN BENEFIT - $975; (F) COMPENSATION REPORTED IN PRIOR FORM 990 (9) - $682,855. CYSTIC FIBROSIS FOUNDATION - HEADQUARTERS. EIN 13-1930701. (A) NAME: V. TWIGG; (B)(I) BASE COMPENSATION: BASE SALARY - $309,865; (B)(II) BONUS & INCENTIVE COMPENSATION: ANNUAL INCENTIVE PLAN BENEFIT (1) $58,255, LONG-TERM INCENTIVE PLAN PAYMENT, WHICH WAS PREVIOUSLY REPORTED (6) - $39,236, LONG-TERM INCENTIVE PLAN TREATMENT AWARD (3) - $70,000; (B)(III) OTHER REPORTABLE COMPENSATION: OTHER BENEFITS INCLUDING TAXABLE GENERAL ORGANIZATION GROUP TERM LIFE INSURANCE PREMIUM - $4,316, SECTION 457(B) PLAN (5) - $18,000; (C) DEFERRED COMPENSATION: RETIREMENT BENEFIT (2) $27,060, LONG-TERM INCENTIVE PLAN BENEFIT (6) - $48,153, SERP (4) - $3,706; (D) NONTAXABLE BENEFITS: EMPLOYER CONTRIBUTION TO GENERAL ORGANIZATION HEALTH PLAN BENEFIT - $19,409, EMPLOYEE CONTRIBUTION TO FLEXIBLE SPENDING ACCOUNT BENEFIT - $2,550, EMPLOYEE CONTRIBUTION TO GENERAL ORGANIZATION HEALTH PLAN BENEFIT - $7,090; (F) COMPENSATION REPORTED IN PRIOR FORM 990 (9) - $39,236 (1) THIS IS AN AWARD SUBJECT TO, AND BASED ON, ACHIEVEMENT OF ANNUAL PERFORMANCE STANDARDS ESTABLISHED IN ADVANCE BY THE COMPENSATION COMMITTEE OF THE BOARD OF TRUSTEES OF CYSTIC FIBROSIS FOUNDATION HEADQUARTERS ("CFF"), A RELATED ORGANIZATION. THE EXECUTIVE PARTICIPATES BY VIRTUE OF BEING AN OFFICER OF CFF. ANY FINANCIAL PERFORMANCE OBJECTIVES ESTABLISHED UNDER THE INCENTIVE COMPENSATION PLAN DO NOT INCLUDE PROGRAM-RELATED REVENUES (SUCH AS ROYALTY STREAMS, LUMP-SUM PAYMENTS, OTHER PROGRAM-RELATED INCOME, AND SALES PROCEEDS FROM TRANSFER OF THE FOREGOING TO THIRD PARTIES) RELATED TO THE DEVELOPMENT AND APPROVAL OF CF DRUGS. (2) THIS IS THE EMPLOYER CONTRIBUTION MADE UNDER THE CYSTIC FIBROSIS FOUNDATION 401(K) PLAN FOR THE 2015 PLAN YEAR. (3) THIS IS AN AWARD UNDER A PLAN SPONSORED BY CFF, A RELATED ORGANIZATION, WHICH PAYS A SPECIFIED DOLLAR AMOUNT ONLY IF AND WHEN THE FDA APPROVES CERTAIN PRE-SPECIFIED TYPES OF THERAPIES. IN THE EVENT THE EMPLOYEE TERMINATES EMPLOYMENT PRIOR TO FDA APPROVAL OF THE SPECIFIED THERAPY TYPE AND PAYMENT OF THE AWARD, THE EMPLOYEE WILL FORFEIT HIS OR HER RIGHT TO RECEIVE PAYMENT, UNLESS TERMINATION IS DUE TO RETIREMENT OR DISABILITY. THE PLAN WILL TERMINATE ON DECEMBER 31, 2018 UNLESS CFF DETERMINES TO EXTEND THE PLAN.
PART II - CONTINUED	(4) THE SERP IS SPONSORED BY CFF, A RELATED ORGANIZATION. THE EXECUTIVE PARTICIPATES BY VIRTUE OF BEING AN OFFICER OF CFF. HOWEVER, BOTH CFFT AND CFF MAKE CONTRIBUTIONS ON THE EXECUTIVES BEHALF IF THE EXECUTIVE RECEIVES COMPENSATION FROM CFFT (AS AN OFFICER OF CFFT) AND FROM CFF (AS AN OFFICER OF CFF). A. THIS IS AN UNVESTED EMPLOYER CONTRIBUTION TO THE SERP. B. SERP INTERESTS ARE FORFEITED BY THE PARTICIPANT IF THE PARTICIPANT VOLUNTARILY TERMINATES EMPLOYMENT PRIOR TO ATTAINING THE VESTING DATE DESIGNATED BY CFF (WHICH IS EITHER A SPECIFIED AGE OR DATE, DEPENDING ON THE PARTICIPANT). C. SERP INTERESTS ARE HELD IN A TRUST SUBJECT TO THE CLAIMS OF CFF'S BANKRUPTCY CREDITORS. IN THE EVENT OF A CFF BANKRUPTCY, PARTICIPANTS WOULD BECOME GENERAL UNSECURED CREDITORS OF CFF. D. THE SERP IS A NONQUALIFIED DEFERRED COMPENSATION PLAN. THIS MEANS THAT PARTICIPANTS DO NOT RECEIVE THE TAX BENEFITS AVAILABLE TO PARTICIPANTS IN TAX QUALIFIED RETIREMENT PLANS. FOR EXAMPLE, UNDER CURRENT LAW, INTERESTS UNDER SERPS ARE REPORTABLE AS TAXABLE COMPENSATION WHEN THEY BECOME VESTED, EVEN IF THOSE AMOUNTS ARE NOT YET PAYABLE TO THE PARTICIPANT (AND EVEN IF THOSE AMOUNTS ARE NEVER PAID TO THE PARTICIPANT). E. THE SERP'S DESIGN WAS REVIEWED AND OPINED UPON AS REASONABLE BY AN INDEPENDENT COMPENSATION CONSULTANT. SERP CONTRIBUTION AMOUNTS WERE DETERMINED BY AN INDEPENDENT ACTUARY. F. CFF RETAINS THE RIGHT TO AMEND OR TERMINATE THE SERP AT ANY TIME. (5) THE 457(B) PLAN IS SPONSORED BY CFF, A RELATED ORGANIZATION. THE EXECUTIVE PARTICIPATES BY VIRTUE OF BEING AN OFFICER OF CFF. HOWEVER, BOTH CFFT AND CFF MAKE CONTRIBUTIONS ON THE EXECUTIVES BEHALF IF THE EXECUTIVE RECEIVES COMPENSATION FROM CFFT (AS AN OFFICER OF CFFT) AND FROM CFF (AS AN OFFICER OF CFF). A. THIS IS A VESTED CONTRIBUTION TO THE 457(B) PLAN FOR THE REPORTING PERIOD. B. IN THE EVENT OF A CFF BANKRUPTCY, PARTICIPANTS ARE GENERAL UNSECURED CREDITORS OF CFF. C. DISTRIBUTIONS FROM THE 457(B) PLAN MAY NOT BE ROLLED-OVER TO AN IRA OR QUALIFIED PLAN (BUT MAY ONLY BE ROLLED-OVER TO ANOTHER 457(B) PLAN). D. THE 457(B) PLAN'S DESIGN WAS REVIEWED AND OPINED UPON AS REASONABLE BY AN INDEPENDENT COMPENSATION CONSULTANT. AN INDEPENDENT ACTUARY DEVELOPED THE CONTRIBUTION FORMULA PURSUANT TO WHICH 457(B) CONTRIBUTION AMOUNTS ARE DETERMINED. CONTRIBUTIONS TO THE 457(B) PLAN ARE SUBJECT TO ANNUAL IRS LIMITS (CURRENTLY $18,000). E. CFF RETAINS THE RIGHT TO AMEND OR TERMINATE THE 457(B) PLAN AT ANY TIME. (6) THIS PLAN PROVIDES FOR AWARDS THAT RELATE TO A THREE-YEAR PERFORMANCE PERIOD, SUBJECT TO, AND BASED ON, ACHIEVEMENT OF PERFORMANCE OBJECTIVES ESTABLISHED IN ADVANCE BY THE COMPENSATION COMMITTEE OF THE BOARD OF TRUSTEES OF CFF, A RELATED ORGANIZATION. THE INDIVIDUALS PARTICIPATE BY VIRTUE OF BEING OFFICERS OF CFF. HOWEVER, IF AN INDIVIDUAL ALSO IS AN OFFICER OF CFFT AND RECEIVES COMPENSATION FROM CFFT, A PORTION OF THE INDIVIDUALS AWARD IS PAID BY CFFT. ANY FINANCIAL PERFORMANCE OBJECTIVES ESTABLISHED UNDER THE INCENTIVE COMPENSATION PLAN DO NOT INCLUDE PROGRAM-RELATED REVENUES (SUCH AS ROYALTY STREAMS, LUMP-SUM PAYMENTS, OTHER PROGRAM-RELATED INCOME, AND SALES PROCEEDS FROM TRANSFER OF THE FOREGOING TO THIRD PARTIES) RELATED TO THE DEVELOPMENT AND APPROVAL OF CF DRUGS. EACH YEAR, A NEW THREE-YEAR PERFORMANCE PERIOD BEGINS. AS REQUIRED BY THE FORM 990 INSTRUCTIONS, THE AMOUNTS REPORTED IN COLUMN (C) ON THIS FORM 990 REFLECT AN ESTIMATE OF THE PORTION OF EACH AWARD THAT THE EXECUTIVE ACCRUED UNDER THE PLAN FOR PERFORMANCE IN 2015 (I.E., WITH RESPECT TO THE 2013-2015, 2014-2016 AND THE 2015-2017 PERFORMANCE PERIODS), BUT THE AMOUNTS REPORTED IN COLUMN (C) HAVE NOT BEEN EARNED, AWARDED OR PAID UNDER THE PLAN. THE INDIVIDUAL MUST BE EMPLOYED ON 12/31/15, 12/31/16 AND 12/31/17 TO BE ELIGIBLE TO RECEIVE FULL PAYMENT OF THE AWARD FOR THE 2013-2015, 2014-2016, AND THE 2015-2017 PERFORMANCE PERIODS, RESPECTIVELY. THE AWARD RELATING TO THE 3-YEAR PERFORMANCE PERIOD ENDING 12/31/14 WAS PAID IN 2015, AND IS PROPERLY REPORTED AGAIN (AS COMPENSATION IN COLUMN (B)(II)) ON THIS FORM 990 (EVEN THOUGH AN ESTIMATE OF THE PORTION OF THIS AWARD THAT THE EXECUTIVE ACCRUED UNDER THE PLAN FOR PERFORMANCE IN 2014, 2013 AND 2012 WAS REPORTED IN COLUMN (C) OF THE FORM 990 FOR EACH OF THOSE YEARS). (7) THIS WAS AN AWARD PAID TO DR. BEALL UPON HIS RETIREMENT AS CEO OF CFF, FULFILLING THE TERMS OF HIS CONTRACT AND RECOGNIZING THE SIGNIFICANT CONTRIBUTIONS AND YEARS OF SERVICE (21-YEARS AS CEO AND 14-YEARS AS EXECUTIVE VICE PRESIDENT). THE AWARD WAS PAID BY CFFT WITH RESPECT TO HIS SERVICE AS AN OFFICER OF CFFT, AND BY CFF WITH RESPECT TO HIS SERVICE AS AN OFFICER OF CFF. THE AWARD WAS REVIEWED AND OPINED ON AS REASONABLE AND MARKET-COMPETITIVE BY THE CFF BOARD OF TRUSTEES INDEPENDENT COMPENSATION CONSULTANTS AND REVIEWED IN DETAIL AND APPROVED (IN THE MANNER SPECIFIED IN IRS REGULATIONS) BY THE CFF BOARDS INDEPENDENT COMPENSATION COMMITTEE. (8) THIS AMOUNT BECAME VESTED AND TAXABLE IN 2015 UNDER THE SERP DESCRIBED IN FOOTNOTE (4) ABOVE, UNDER WHICH DR. BEALL RECEIVED CONTRIBUTIONS FROM 2013-2015. AS REQUIRED, THE CONTRIBUTIONS TO THIS SERP THAT GENERATED THE AMOUNT REPORTED IN COLUMN B(III) OF THIS FORM 990 WERE REPORTED ON PRIOR YEARS' FORM 990S IN COLUMN (C). (9) THIS AMOUNT, ALTHOUGH ALSO INCLUDED IN COLUMN B OF THIS FORM 990, HAS ALREADY BEEN REPORTED AS COMPENSATION ON PRIOR YEARS' FORM 990S, AND THEREFORE (AS REQUIRED BY THE INSTRUCTIONS) IS DOUBLE-REPORTED HERE. (10) THIS WAS SEVERANCE PAID TO MR. MATTINGLY BY CFF UPON HIS RETIREMENT AS EXECUTIVE VICE PRESIDENT AND COO OF CFF, AFTER A 37-YEAR TENURE. THE AWARD WAS REVIEWED AND OPINED ON AS REASONABLE FROM A MARKET-COMPETITIVE STANDPOINT BY THE CFF BOARD OF TRUSTEES INDEPENDENT COMPENSATION CONSULTANTS AND REVIEWED IN DETAIL AND APPROVED (IN THE MANNER SPECIFIED IN IRS REGULATIONS) BY THE CFF BOARDS INDEPENDENT COMPENSATION COMMITTEE. (11) THIS AMOUNT BECAME VESTED AND TAXABLE IN 2015 UNDER THE SERP DESCRIBED IN FOOTNOTE (4) ABOVE, UNDER WHICH MR. MATTINGLY RECEIVED CONTRIBUTIONS FROM 2007-2015. AS REQUIRED, THE CONTRIBUTIONS TO THIS SERP THAT GENERATED THE AMOUNT REPORTED IN COLUMN B(III) OF THIS FORM 990 WERE REPORTED ON PRIOR YEARS' FORM 990S IN COLUMN (C).

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (7 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
GOVERNING BODY APPOINTMENTS	PART VI, SECTION A, LINE 7A THE MAJORITY OF THE ORGANIZATIONS BOARD MEMBERS ARE DESIGNATED BY THE BOARD OF TRUSTEES OF THE CYSTIC FIBROSIS FOUNDATION. THE OTHERS ARE EX-OFFICIO, APPOINTED TO THE BOARD BY THE BYLAWS.
REVIEW OF 990 BY GOVERNING BODY	PART VI, SECTION B, LINE 11B THE ORGANIZATIONS BOARD OF DIRECTORS RECEIVES A DRAFT OF THE FORM 990 PRIOR TO ITS BEING FILED, WITH SUFFICIENT TIME FOR REVIEW AND COMMENT ALLOWED. THE ORGANIZATIONS ERISA ATTORNEYS REVIEW THE EXECUTIVE COMPENSATION SECTIONS OF THE FORM 990 TO ENSURE COMPLETENESS AND ACCURACY. THE AUDIT COMMITTEE ALSO REVIEWS THE FORM 990 AS PART OF ITS CHARTERED RESPONSIBILITIES. IN ALL CASES THE CYSTIC FIBROSIS FOUNDATION THERAPEUTICS BOARD OF DIRECTORS RECEIVED A COMPLETE COPY OF THE FINAL FORM 990 BEFORE IT IS FILED.
CONFLICT OF INTEREST MONITORING	PART VI, SECTION B, LINE 12C A CONFLICT OF INTEREST DISCLOSURE STATEMENT IS COMPLETED ANNUALLY BY EACH BOARD MEMBER AND OFFICER. AS REQUIRED WITHIN THE BYLAWS, ANY POTENTIAL CONFLICTS OF INTEREST MUST BE REPORTED TO THE BOARD AS THEY ARISE. WHEN ANY MATTER IS DEEMED A POTENTIAL CONFLICT OF INTEREST AND REQUIRES ACTION BY THE BOARD OF DIRECTORS, THE INTERESTED DIRECTOR OR OFFICER IS REQUIRED TO RETIRE FROM THE ROOM IN WHICH THE BOARD IS MEETING, MAY NOT PARTICIPATE IN THE FINAL DELIBERATION OF THE MATTER, AND MAY NOT VOTE ON THE MATTER. THE ORGANIZATION ENFORCED THE POLICY DURING 2015 AND HAD NO CONFLICTS OF INTEREST AS DEFINED BY THE POLICY.
DETERMINING COMPENSATION	PART VI, SECTION B, LINE 15A AND 15B THE TOTAL COMPENSATION OF EXECUTIVES AT THE ORGANIZATION IS SPECIFICALLY DESIGNED TO ATTRACT AND RETAIN THE HIGHEST QUALIFIED EXECUTIVE AND MEDICAL TALENT TO FULFILL THE CRITICALLY IMPORTANT MISSION OF CURING CYSTIC FIBROSIS AND PROVIDING ALL PEOPLE WITH THE DISEASE THE OPPORTUNITY TO LEAD FULL, PRODUCTIVE LIVES. CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. SHARES OFFICERS WITH CYSTIC FIBROSIS FOUNDATION, A RELATED ORGANIZATION. THE INDEPENDENT COMPENSATION COMMITTEE OF THE CF FOUNDATION'S BOARD OF TRUSTEES FOLLOWS THE PROCESS DESCRIBED IN THE IRS INTERMEDIATE SANCTIONS RULES WHEN DETERMINING COMPENSATION FOR EXECUTIVES OF THE ORGANIZATION. SPECIFICALLY, THE COMMITTEE: (1) IS COMPOSED ENTIRELY OF NON-EMPLOYEE VOLUNTEER DIRECTORS WHO HAVE NO FAMILIAL, BUSINESS OR SIGNIFICANT PERSONAL RELATIONSHIPS WITH THE ORGANIZATION OR ITS EXECUTIVES. (2) ASSESSES THE SHORT-TERM AND LONG-TERM CONTRIBUTION AND PERFORMANCE OF EACH EXECUTIVE IN MEETING VERY DEFINITIVE AND QUANTIFIABLE OBJECTIVES FOCUSED ON THE ORGANIZATION'S MISSION SUCCESS. (3) ENGAGES AN INDEPENDENT COMPENSATION CONSULTING FIRM TO COMPILE APPROPRIATE COMPARABILITY DATA (INCLUDING COMPENSATION MARKET INFORMATION FOR PEERS WITH WHOM THE ORGANIZATION COMPETES FOR EXECUTIVE TALENT) FOR COMMITTEE RELIANCE. THE COMMITTEE MEETS WITH REPRESENTATIVES OF THE CONSULTING FIRM TO REVIEW THIS DATA IN DETAIL. (4) REVIEWS ALL ELEMENTS OF EACH EXECUTIVE'S TOTAL COMPENSATION, INCLUDING BUT NOT LIMITED TO BASE SALARY, BONUSES, PERQUISITES, FRINGE BENEFITS, AND INCENTIVE AND DEFERRED COMPENSATION ARRANGEMENTS. UPON THE EXECUTIVES HIRE, AND AT EACH POINT IN TIME THEREAFTER AT WHICH A NEW OR REVISED COMPENSATION ARRANGEMENT IS UNDER CONSIDERATION WITH RESPECT TO THE EXECUTIVE, THE COMMITTEE MEETS WITH ITS INDEPENDENT COMPENSATION CONSULTING FIRM BEFORE THE ARRANGEMENT IS IMPLEMENTED TO EVALUATE THE REASONABLENESS OF THE ARRANGEMENT BY COMPARING BOTH THE ARRANGEMENT ITSELF AND THE EXECUTIVES ENTIRE COMPENSATION PACKAGE TO COMPENSATION PACKAGES PAID BY SIMILARLY SITUATED ORGANIZATIONS FOR FUNCTIONALLY COMPARABLE POSITIONS. (5) DOCUMENTS, CONCURRENTLY WITH ITS DETERMINATION, THE BASIS FOR ITS DETERMINATION IN THE MINUTES OF ITS MEETING. THESE MINUTES ARE REVIEWED, REVISED IF NECESSARY AND APPROVED AT THE FOLLOWING MEETING OF THE COMMITTEE. (6) OBTAINS A WRITTEN LEGAL OPINION CONCERNING THE COMMITTEES COMPLIANCE WITH THE IRS INTERMEDIATE SANCTIONS RULES. THE PROCESS DESCRIBED ABOVE WAS USED TO ESTABLISH COMPENSATION FOR THE FOLLOWING OFFICERS OF THE ORGANIZATION: PRESIDENT & CEO EXECUTIVE VICE PRESIDENT & COO EXECUTIVE VICE PRESIDENT, CFO AND SECRETARY THE PROCESS WAS LAST UNDERTAKEN IN 2014, WITH THE EXCEPTION OF THAT FOR THE CEO POSITION WHICH WAS LAST CONDUCTED IN 2015.
PUBLIC INSPECTION	PART VI, SECTION C THE FORM 1023 FOR THE ORGANIZATION WAS AVAILABLE ON ITS WEBSITE, CFF.ORG, AND THE ORGANIZATION'S WEBSITE PROVIDES A DIRECT LINK TO ITS FORM 990 ON GUIDESTAR.ORG. CFFTS GOVERNING DOCUMENTS (BYLAWS AND ARTICLES OF INCORPORATION) ARE AVAILABLE UPON REQUEST BY CONTACTING THE ORGANIZATION IN WRITING OR BY PHONE. INFORMATION ON HOW TO OBTAIN THE GOVERNING DOCUMENTS IS AVAILABLE ON THE WEBSITE, WWW.CFF.ORG/RESEARCH/CFFT. THE BOARD AND OFFICER CONFLICT OF INTEREST POLICY AND THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS ARE AVAILABLE ON THE WEBSITE, WWW.CFF.ORG/RESEARCH/CFFT/FINANCIALSTATEMENTS.
PART VII, SECTION A	THE FOLLOWING IS AN ESTIMATE OF THE AVERAGE HOURS PER WEEK DEVOTED TO RELATED ORGANIZATIONS BY THE OFFICERS: CYSTIC FIBROSIS CYSTIC FIBROSIS FOUNDATION FOUNDATION GROUP RETURN TITLE HEADQUARTERS FOR THE CHAPTERS ----- ------------- ---------------------- PRESIDENT & CEO 36 4 EXEC. VICE PRESIDENT & COO 50 5 EXEC. VICE PRESIDENT & CFO 50 5
PART VII, SECTION A	REPORTABLE COMPENSATION FROM THE ORGANIZATION THIS AMOUNT WAS PAID TO DR. TORPHY WITH RESPECT TO HIS SERVICES AS AN EMPLOYEE, WHICH TERMINATED ON 12/31/14. HE WAS PAID FOR THOSE SERVICES IN ACCORDANCE WITH THE ORGANIZATION'S STANDARD PAY PRACTICES, WHICH CAUSED HIS FINAL PAYCHECKS TO BE PAID IN THE FIRST TWO PAY DATES DURING 2015. THEREFORE, THE COMPENSATION IS REPORTABLE COMPENSATION FOR 2015. DR. TORPHY RECEIVED NO COMPENSATION AS CHAIRMAN OF THE BOARD OF DIRECTORS OF THE ORGANIZATION.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (2 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	EINEIN	Primary ActivitiesPrimaryActivitiesTxt	Legal Domicile StateLegalDomicileStateCd	Exempt Code SectionExemptCodeSectionTxt	Public Charity StatusPublicCharityStatusTxt	Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt	Controlled OrganizationControlledOrganizationInd
CYSTIC FIBROSIS FOUNDATION- HEADQUARTERS
6931 ARLINGTON RD	BETHESDA	MD	20814	131930701	RESEARCH	DE	501(c)(3)	7	NA	false
CYSTIC FIBROSIS FOUNDATION - GROUP
6931 ARLINGTON RD	BETHESDA	MD	20814	136161105	EDUCATION	DE	501(c)(3)	7	CFF-HQ	false

Field	Value	IRS element (for citing)
Receipt Of Int Annts Rnts Rylts	false	ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org	false	GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org	Yes (true)	GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org	false	LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org	false	LoansOrGuaranteesFromOthOrgInd
Div Related Organization	false	DivRelatedOrganizationInd
Asset Sale To Other Org	false	AssetSaleToOtherOrgInd
Asset Purchase From Other Org	false	AssetPurchaseFromOtherOrgInd
Asset Exchange	false	AssetExchangeInd
Rental Of Facilities To Oth Org	false	RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org	false	RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org	false	PerformOfServicesForOthOrgInd
Perform Of Services By Other Org	false	PerformOfServicesByOtherOrgInd
Sharing Of Facilities	Yes (true)	SharingOfFacilitiesInd
Paid Employees Sharing	Yes (true)	PaidEmployeesSharingInd
Reimbursement Paid To Other Org	false	ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org	false	ReimbursementPaidByOtherOrgInd
Transfer To Other Org	false	TransferToOtherOrgInd
Transfer From Other Org	false	TransferFromOtherOrgInd